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Vibrio cholerae has multiple iron transport systems, one of which involves
heme uptake through the outer membrane receptor HutA.  This study
demonstrates that V. cholerae encodes two additional TonB-dependent heme
receptors, HutR and HasR.  HutR has significant homology to HutA and to other
bacterial outer membrane heme receptors, and the role of HutR in hemin
utilization and its localization in the outer membrane were confirmed.  The hutR
gene was co-transcribed with the upstream gene ptrB, and expression from the
ptrB promoter was negatively regulated by iron.  HasR is most similar to the
hemophore-utilizing heme receptors from Pseudomonas aeruginosa and Serratia
marcescens.  A mutant defective in all three heme receptors was unable to utilize
hemin as an iron source.  HutA and HutR functioned with either V. cholerae
TonB1 or TonB2.  In contrast, hemin uptake through HasR was TonB2-
viii
dependent.  Efficient utilization of hemoglobin as an iron source required HutA
and TonB1.  The triple heme receptor mutant exhibited no defect in its ability to
compete with its Vib- parental strain in an infant mouse model of infection,
indicating that additional iron sources are present in vivo.  V. cholerae utilized
heme derived from marine invertebrate hemoglobins, suggesting that heme may
be available to V. cholerae growing in the marine environment.
Although E. coli TonB and V. cholerae TonB1 exhibit different
specificities for outer membrane receptors, these TonB proteins are similar
enough that functional chimeras can be created between them.  The activities of
the chimeric TonB proteins demonstrated that the C-terminal one-third of TonB
constitutes a functional domain responsible for receptor specificity.  A Pro238Thr
substitution in V. cholerae TonB1 resulted in the ability of TonB1 to recognize a
wider range of receptors, indicating that very C-terminal end of TonB1
determines receptor specificity.  Domain-switching experiments between E. coli
ChuA and V. cholerae HutA showed that the TonB box heptapeptide at the N-
terminus of these receptors does not contain specificity determinants.  Instead,
specificity was controlled by the residue immediately preceding the TonB box.
Taken together, these data suggest that functional interactions take place between
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I.  INTRODUCTION
A.  Microbial iron acquisition strategies
1.  IRON REQUIREMENTS AND AVAILABILITY
Most living organisms require iron for a variety of cellular processes
including electron transport, DNA synthesis, and antioxidant defense (46, 180).
Iron is one of the most abundant elements in nature; nevertheless, acquiring
enough iron for growth poses a significant problem for bacterial pathogens.  Iron
forms insoluble complexes at physiological pH in the presence of oxygen, and
thus the iron is not easily accessible to microorganisms living in the natural
environment (16).  Pathogens that colonize humans also encounter an iron-
limiting environment.  Although the human body contains 4-5 grams of iron,
virtually all of this iron is sequestered within cells in the form of heme proteins
and ferritin.  The small amounts of extracellular iron are quickly bound by host
iron-binding proteins such as transferrin (Tf) in serum and lactoferrin (Lf) in
secretions.  Upon tissue damage, heme proteins may be released from cells and
are a potential source of iron for pathogens.  To limit the amount of heme in the
extracellular environment, free heme is bound by the circulating host serum
proteins albumin and hemopexin, and hemoglobin is bound by haptoglobin
(reviewed in (23, 138, 180).  The ability to successfully compete with the host for
iron is an important determinant of microbial pathogenesis (129).
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Another problem associated with iron uptake by bacterial cells stems from
the potential of iron for catalyzing production of reactive hydroxyl radicals.
Hydroxyl radicals are especially damaging to DNA.  The uptake and storage of
iron must therefore be tightly regulated and coordinated with the cell’s needs,
such that the requirements for iron are met but not exceeded (23).
2.  OVERVIEW OF HIGH AFFINITY IRON TRANSPORT IN GRAM NEGATIVE
BACTERIA
Most iron sources used by Gram negative pathogens are too large (> 600
Da) to pass through porins in the outer membrane, or too scarce to bioaccumulate
in any significant amount by diffusion.  Rather, iron complexes are transported
across the outer membrane via high-affinity outer membrane receptors that are
specific for their substrates (23, 65, 173).  An overview of high affinity iron
transport in Gram negative bacteria is shown in Figure 1.  Following binding of
an iron complex to its cognate receptors, the iron substrate is actively shunted
through the transmembrane receptor pore into the periplasmic space.  The TonB,
ExbB and ExbD proteins play an essential role in the transport process by
transducing energy produced at the cytoplasmic membrane to the receptors for
iron complexes in the energy-deficient outer membrane (12, 14, 133).  By
interacting directly with ligand-bound receptors, energized TonB is thought to
induce a conformational change in these receptors that facilitates internalization
of the bound substrates (14, 133, 153).  Once in the periplasm, iron complexes are
shuttled to the cytoplasmic membrane by a substrate-specific periplasmic binding
3
Figure 1.  High affinity transport of iron substrates across the Gram negative cell
envelope.
An iron complex is bound by its cognate receptor in the outer membrane.  Energy
transduction by the TonB, ExbB, ExbD complex promotes the subsequent
transport of the bound substrate into the periplasm.  Once in the periplasm, the
iron complex is shuttled to a substrate-specific inner membrane permease
complex by a substrate-specific periplasmic binding protein (PBP).  Binding of
the substrate-loaded PBP to the inner membrane permease complex triggers ATP
hydrolysis and facilitates transport of the substrate into the cytoplasm.
4
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protein (PBP).  The substrate-bound PBP delivers its cargo to an integral inner
membrane complex that is associated with ATPases at the cytoplasmic face of the
membrane.  The PBP-dependent transport systems (PBT) belong to the ABC
(ATP binding cassette) superfamily of bacterial transporters (15, 138).  Binding of
the substrate-loaded PBP to the inner membrane complex triggers ATP hydrolysis
and facilitates transport of the substrate into the cytoplasm.  It is not currently
known whether the PBP directly contacts the cytoplasmic ATPases, or whether a
signal is transmitted through the integral membrane components of the transport
complex to indicate docking of the substrate-bound PBP (16).
3.  SPECIFIC HIGH AFFINITY IRON UPTAKE SYSTEMS IN GRAM NEGATIVE
BACTERIA
a.  Siderophore mediated iron acquisition
One of the most common strategies for bacterial iron acquisition is the
synthesis and secretion of siderophores, low molecular weight (500-1000 Da)
ferric iron chelating compounds with very high affinity for iron (Kaff > 10
30).  In
the extracellular environment, siderophores solubilize iron from insoluble
complexes, and the iron-bound siderophores are subsequently taken up by the cell
via specific cell surface receptors (42, 118, 138).  Since siderophore-chelated iron
is prevented from participating in oxy-radical production, siderophores also
provide a solution to the toxicity problems associated with iron acquisition (23).
The iron binding capacity of siderophores is considered strong enough to remove
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iron from host iron-sequestering molecules such as Tf and Lf.  Thus, these host
compounds are potentially available as iron sources to siderophore-producing
pathogens (138).  Siderophores are synthesized and secreted under conditions of
iron stress, and can be readily detected in the supernatant of cells grown in iron-
limited media (118).  Although chemically diverse, many of the siderophores
produced by pathogenic bacteria can be classified as catechols, hydroxamates, or
thiazolines (138).  The prototype of a catechol siderophore is enterobactin, a
cyclic compound made up of three molecules of 2,3-dihydroxybenzoylserine
connected via ester linkages first identified in Salmonella typhimurium (131) and
in Escherichia coli (122).  Enterobactin is transported across the outer membrane
of E. coli via the receptor FepA.  An example of a hydroxamate siderophore is
aerobactin, synthesized by certain E. coli and Shige l la strains (130).
Yersiniabactin, produced by Yersinia spp., contains two thiazoline rings as well as
a phenolate group, all of which have the potential for coordinating iron (138).
Many pathogens also use siderophores produced by other microorganisms,
collectively termed xenosiderophores.  The fungal hydroxamate siderophore
ferrichrome, for example, is widely used by bacterial species.  Ferrichrome
transport across the E. coli outer membrane occurs via the receptor FhuA.
Following transport across the cell envelope, ferrisiderophores release
their bound iron in the cytosol.  Because siderophores bind Fe(II) much less
tightly than Fe(III), reduction of the siderophore-bound Fe(III) has been proposed
as a mechanism for liberating the iron from ferrisiderophores (42, 46, 138).
Reductases capable of reducing ferrisiderophores in vitro have been identified in
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many bacterial and fungal species (138).  Following release of the iron, some
siderophores are secreted once again into the extracellular environment, where
they can participate in another round of iron scavenging.  Aerobactin, for
example, may be recycled up to three times before being degraded (46).  Others,
such as enterobactin, are degraded concomitantly with reduction of the bound
iron.  The enzyme responsible for enterobactin hydrolysis and iron release in the
cytoplasm of E. coli is Fes, a ferrisiderophore reductase with esterase activity
(17).
b.  Utilization of host iron-binding proteins
The direct utilization of the host iron binding glycoproteins Tf and Lf as sources
of iron has been best described in members of the Neisseriaceae and
Pasteurellaceae families (63).  The ability to use Tf and Lf directly may be
particularly important in these non-siderophore producing organisms.  It was
demonstrated genetically that there are separate cell surface receptors for Tf and
Lf in Neisseria gonorrhoeae (9), and the presence of genes encoding specific
receptors for these substrates has been documented for most of the bacterial
species that use either or both of these glycoproteins directly (126).  The Tf and
Lf cell surface receptors in the families Neisseriaceae and Pasteurellaceae are
each composed of two proteins, both of which are capable of binding the
substrate:  Tf or Lf binding protein A (TbpA/LbpA), and Tf or Lf binding protein
B (TbpB/LbpB).  The TbpA/LbpA proteins are integral outer membrane proteins
that resemble receptors for siderophores and other iron substrates.  The
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TbpB/LbpB proteins are lipoproteins that are peripherally associated with the
outer membrane via an N-terminal lipid moiety (reviewed in (63).  There is a high
level of variation in LbpB among members of the same species, consistent with
exposure of this protein at the cell surface where variation may aid in evading the
host immune response.  A recent model of the meningococcal Tf receptor
proposes that TbpB provides the initial binding site for Tf, and that this binding
ensures the proper orientation and proximity of Tf to a closely associated TbpA
dimer.  Subsequent binding of iron-loaded Tf by TbpA may result in a distortion
of the Tf molecule, promoting release of the Tf-bound iron into the TbpA pore
(10).
c.  Utilization of heme as an iron source
Heme is by far the most abundant source of iron in the human body, and
many pathogens have evolved mechanisms to take advantage of this reservoir
(reviewed in Wandersman and Stojiljkovic, 2000 (175) and Genco and Dixon,
2001 (58)).  Pathogens that multiply intracellularly can use heme directly;
however, gaining access to intracellular heme stores is not trivial for extracellular
pathogens.  To facilitate the release of intracellular nutrients, many extracellular
pathogens produce hemolysins/cytolysins that damage eukaryotic cells, causing
intracellular heme proteins to leak into the extracellular milieu.  V. cholerae El
Tor strains produce the cytotoxic hemolysin Hly under conditions of iron
deprivation, consistent with a role for Hly in iron acquisition (158).  The
Pseudomonas aeruginosa exotoxin A, which is cytotoxic toward a wide range of
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eukaryotic cells, (8) and the Serratia marcescens ShlA hemolysin (132) are
similarly under the control of iron.
Host heme-containing proteins are generally thought to be too large be
taken up intact by the bacterial cell.  One mechanism for liberating heme
sequestered within hemoglobin and hemoglobin-haptoglobin, or bound to a serum
protein carrier such as hemopexin or albumin, is the synthesis and secretion of
proteases that degrade host heme proteins extracellularly.  V. vulnificus
synthesizes an exocellular protease that is required for the utilization of
hemoglobin, hemoglobin-haptoglobin, and heme-hemopexin as sources of iron
(121).  The lysine-specific cysteine protease Kgp produced by Porphyromonas
gingivalis binds to and degrades hemoglobin, and also exhibits proteolytic activity
towards haptoglobin and hemopexin (101, 155).  In addition, Kgp is a heme-
binding protein, indicating that this protein is able to bind heme as it is released
from the protein carrier.  The pathogenic E. coli strain EB1 similarly produces a
heme-binding hemoglobin protease, Hbp (128).
Several pathogens, including S. marcescens (96), Haemophilus influenzae
(38) and Pseudomonas spp. (76, 100) synthesize and secrete hemophores, small
extracellular proteins capable of binding heme in the extracellular environment.
Hemophores are functionally similar to siderophores:  after being secreted from
the bacterial cell into the extracellular medium, they bind their substrate and
deliver it to specific receptors at the bacterial cell surface.  The best-characterized
hemophore to date is the S. marcescens HasA protein, which is involved in
capturing heme from hemoglobin (96).  Secretion of the 19 kDa HasA proteins
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depends upon a secretion signal within the C-terminal part of the molecule, and
occurs via an ABC export system composed of HasD, HasE, and HasF (97).  The
mechanism by which HasA obtains heme from hemoglobin is not clear.  HasA
does not form a stable complex with hemoglobin, and if there is a direct transfer
of the heme molecule from the hemoprotein to the hemophore, it may involve
only a transient complex (98).  HasA has a higher affinity for heme than
hemoglobin does (98), and it is possible HasA acquires its heme simply by
efficiently binding up any heme that dissociates from hemoglobin.  has-like genes
have been identified in P. aeruginosa (100, 125) and in Pseudomonas fluorescens
(76, 99) and are required for efficient utilization of hemoglobin as an iron source
in these organisms.   Hemophore systems that are functionally similar, but
genetically distinct from the HasA systems have also been identified.  HxuA, an
extracellular heme-binding protein which is both soluble and cell-surface
associated, is involved in obtaining heme from heme-hemopexin in H. influenzae
(38, 39).  The P. gingivalis secreted protein Kgp, which degrades hemoglobin and
binds the liberated heme, has been shown to interact with a cell surface receptor
HmuR, and may function in the delivery of heme to this receptor (155).
  The ability to bind heme, hemoglobin, and other host heme-containing
proteins directly via cell surface receptors has been documented for a number of
pathogenic species (58, 175).  These receptors share many sequence features,
suggesting that they may use similar mechanisms for binding and/or transport of
heme.  In particular, two amino acid sequence motifs, FRAP and NPNL, appear to
be conserved among a large number of heme and hemoglobin receptors (11, 175).
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Several histidine residues required for Y. enterocolitica  HemR receptor function
are conserved in other heme receptors as well (11).  Ultimately, whether the heme
carrier is a bacterial hemophore, or a host-derived heme protein, only the heme
moiety is transported into the cell.
Receptors involved in heme acquisition can be divided into several
categories, depending on their substrate specificities.  A large number of
receptors, including V. cholerae HutA (68, 69), Shigella dysenteriae ShuA (112,
113), E. coli 0157:H7 ChuA (168), V. vulnificus HupA (106), P. aeruginosa PhuR
(125), Yersinina pestis HmuR (167), H. influenzae HxuC (37), and Plesiomonas
shigelloides HugA (71) have been shown genetically and/or biochemically to be
involved in the transport of free heme.  Although many of these receptors are also
required for utilization of heme-containing proteins such as hemoglobin as iron
sources, no direct binding to heme-protein substrates has been demonstrated for
this group of receptors.  For example, V. cholerae uses both heme and
hemoglobin as iron sources, and the V. cholerae receptor HutA confers both heme
and hemoglobin utilization in E. coli (68, 69).  However, hemoglobin binding
assays have failed to show binding of hemoglobin to the surface of V. cholerae (S.
M. Payne, unpublished results), suggesting that liberation of heme in preparation
for uptake occurs independently of the cell surface receptor.  Similarly, the H.
influenzae outer membrane receptor HxuC was shown to be involved in
utilization of hemoglobin, but no binding to hemoglobin was detected (37).  The
E. coli 0157:H7 heme receptor ChuA is necessary for growth using either heme or
hemoglobin as iron sources (168).  However, based on its similarity to the
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S. dysenteriae heme receptor ShuA (100% similarity; 99% identity) it is unlikely
that ChuA is a hemoglobin receptor, since S. dysenteriae does not use hemoglobin
as an iron source.  Thus, hemoglobin utilization in E. coli 0157:H7 may involve a
mechanism not found in S. dysenteriae that facilitates the release of heme from
hemoglobin prior to heme binding by ChuA.
The second category of receptors includes those that have been shown
biochemically to bind hemoglobin and/or hemoglobin-haptoglobin directly.  Most
of these receptors are capable of binding free heme as well, suggesting that an
initial protein contact is made between the receptor and the substrate, followed by
release of the heme into a secondary binding site on the receptor.  Neisseria
meningitidis expresses two distinct hemoglobin receptors:  HpuAB, a two-
component hemoglobin/hemoglobin-haptoglobin receptor similar to the Tf and Lf
receptors (102, 104), and HmbR, which is specific for hemoglobin (159, 160).
Both of these receptors are phase-variable (103, 141).  Phase-variation may play a
role in evasion of the host immune response during an infection, and may enable a
given strain to infect the same host more than once.  Hemoglobin-utilizing
N. gonorrhoeae strains express only the HpuAB receptor (32).  The gene
encoding hmbR appears to be defective in the N. gonorrhoeae strains tested (160).
H. influenzae produces three hemoglobin- and hemoglobin-haptoglobin-binding
proteins, HgpA, HgpB and HgpC, all of which undergo phase-variation (36, 115).
A mutant defective in all three receptors was unable to use hemoglobin-
haptoglobin, and no longer bound hemoglobin to the cell surface (115).  However,
growth stimulation with hemoglobin was still observed, and this growth has been
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attributed to the heme receptor HxuC (37).  Finally, the Y. enterocolitica receptor
HemR and the P. gingivalis receptor HmuR both participate in hemoglobin
utilization, and have been shown to bind hemoglobin directly (11, 152).
The heme-hemopexin receptors constitute the third category of receptors.
Direct binding of heme-hemopexin to bacterial cells has only been described in
H. influenzae.  H. influenzae HxuA binds both heme and heme-hemopexin
extracellularly, and is found both in the extracellular medium and in association
with the cell surface.  Thus, HxuA may function both as a hemophore and as a
cell surface receptor for heme-hemopexin.  In addition to HxuA, many
H. influenzae strains produce a 57 kDa cell surface exposed protein that facilitates
binding of heme-hemopexin to the bacterial cell independently of HxuA.  This
protein has been proposed to function as an outer membrane receptor for heme-
hemopexin complexes (179).
The final set of receptors includes those specific for hemophores.  In
S. marcescens, heme-bound HasA delivers its heme to the outer membrane
receptor HasR, and although HasR is capable of transporting free heme in the
absence of HasA, heme uptake is 100-fold more efficient in the presence of the
hemophore (60).  HasR binds both heme-bound and unbound HasA, suggesting
that there are direct protein-protein contacts involved in binding of the hemophore
to its receptor (95).  A HasR type hemophore receptor has also been identified in
P. aeruginosa, and is required for hemophore-dependent heme uptake in this
organism (125).  The P. gingivalis outer membrane receptor HmuR has been
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classified as a hemoglobin receptor, but may also function like a hemophore
receptor by binding to the extracellular hemophore-like protein Kgp (127).
Once heme enters the cytosol, it may be incorporated directly into heme-
containing proteins, or it may undergo oxidative cleavage by a heme oxygenase to
release the heme iron (58).  A heme oxygenase from a bacterial pathogen was first
characterized in the Gram positive pathogen Corynebacterium diphtheriae.
C. diphtheriae HmuO exhibits heme oxygenase activity in vitro (33) and is
required for utilization of heme as an iron source (147).  Heme oxygenases have
now been identified in several Gram negative pathogens as well, including in
Neisseria spp. (186, 187) and P. aeruginosa (139).
B.  Mechanisms of TonB-dependent transport across the outer
membrane
1.  TONB-DEPENDENT OUTER MEMBRANE RECEPTORS
TonB-dependent receptors from many different organisms have been
characterized and exhibit significant overall sequence conservation.  Based on
structural information available for two TonB-dependent receptors from E. coli,
FepA (18) and FhuA (52, 108), it is predicted that all TonB-dependent receptors
have a similar basic design:  a 22-stranded transmembrane β-barrel porin structure
with a unique N-terminal domain that fits tightly into the barrel like a plug from
the periplasmic side (Fig. 2).  The transmembrane β-strands are connected by
short turns at the periplasmic face, and by long loops at the external face of the
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Figure 2.  Ribbon diagram of the E. coli enterobactin receptor FepA.
The diagram shows the β-barrel structure of FepA in green, and the N-terminal
plug domain in red.  A section of the β-barrel has been made transparent to show
the location of the plug domain within the β-barrel pore.  The long extracellular
loops are labeled.  The red sphere shows the putative position of the iron in
ferrienterobactin.  The location of the TonB box is indicated.  Reprinted from










barrel.  These loops extend into the extracellular environment and are likely to be
involved in the initial binding of the substrate (28, 119).  Following its initial
adsorption, the substrate appears to bind with high affinity further into the channel
(28, 108).  The structure of ligand-bound FhuA shows that FhuA binds
ferrichrome via residues in both the barrel and the N-terminal plug domain (108).
Interestingly, a FhuA variant missing the plug domain (FhuA∆5-160) still bound
ferrichrome, suggesting that the plug domain residues are dispensable for binding
(13).  Further, a hybrid composed of the FhuA β-barrel and the FepA N-terminal
plug bound ferrichrome, but not enterobactin, indicating that residues in the β-
barrel confer ligand specificity, and that ligand-specific contacts between the N-
terminal domain and the substrate are not absolutely required for substrate
binding (148).  In all binding studies, however, the plugless and hybrid receptor
variants had significantly lower binding capacities than the wild type receptors
(148), suggesting that the plug domain may be important for efficient binding
under conditions of limited substrate availability.
The mechanism of substrate transport and the involvement of TonB in this
process cannot be inferred from the structural information alone.  In order for a
substrate to pass through the channel, the plug domain must either come out of the
barrel entirely, or must undergo some reorganization within the barrel to allow
passage of the substrate.  The plug domain is held in the β-barrel by a large
network of hydrogen bonds and salt bridges, and ousting of the plug in order to
facilitate passage of a substrate does not seem energetically feasible.  It is also not
clear how any reorganization of the plug domain within the barrel would create a
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space large enough to accommodate the substrate.  One model proposes that the
plug domain undergoes an entropically favorable unfolding, which, with help
from TonB, would offset the energy costs involved in disrupting surface
interactions within the barrel (172).  The unfolded plug domain might then come
out of the barrel entirely, which would help explain the TonB-dependent passage
of much larger molecules than siderophores, such as colicins and siderophore
antibiotics, through the siderophore receptors.  This model fails, however, to
account for the large input of energy that would be required for refolding and
insertion of the plug domain into the barrel once more.  Interestingly, transport of
ferrichrome through a plugless FhuA variant required TonB, indicating that
removal of the plug domain is not sufficient for substrate internalization, and that
interactions between TonB and the barrel also participate in the passage of the
ligand through the receptor pore (13).
2.   STRUCTURE OF TONB AND ORGANIZATION OF TO NB FUNCTIONAL
DOMAINS
E. coli TonB (Fig. 3) is a 26 kDa protein that is anchored in the
cytoplasmic membrane via its uncleaved N-terminal signal sequence (134).  The
association of TonB with the inner membrane requires the ExbB and ExbD
proteins (94), both of which interact directly with TonB (73, 90).  This interaction
is necessary for energy transduction by TonB (1, 79).  While ExbB extends into
the cytoplasm (47, 82), ExbD primarily occupies the periplasm (81), and together
they may from a heterohexameric complex directly involved in energizing
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Figure 3.  Organization of E. coli TonB functional domains.
The N-terminal anchor domain (amino acid residues 1-32) is shown in red.  The
central proline-rich domain (amino acid residues 66-100) is hatched.  The C-
terminal dimerization domain (amino acid residues 164-239) is shown in blue.
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TonB (73).  The interaction between TonB and ExbB is well characterized and
involves a set of conserved residues on one face of the α-helical transmembrane
N-terminal anchor domain of TonB (88-90).  These residues form a HXXXS motif
that is required for the coupling of TonB to the electrochemical gradient of the
inner membrane (88).  The precise nature of the interaction between TonB and
ExbD has not been defined (73).
  From the cytoplasmic membrane, TonB extends into the periplasm (144)
and may span the periplasmic space in order to make direct contacts with
components of the outer membrane (153).  The central proline-rich domain of
TonB may be critical for the ability of TonB to bridge the periplasmic space by
allowing TonB to adopt a rigid extended conformation (91).  Deletion of this
region only affects TonB activity under conditions of high osmolarity, conditions
which may cause a widening of the periplasmic space (91, 149).
Membrane fractionation experiments have demonstrated that TonB
localizes with both the inner and outer membranes, suggesting intimate
associations with both membranes (94).  Several lines of evidence support the
hypothesis that TonB associates with the outer membrane via its C-terminal
domain.  A TonB variant that lacks the C-terminal 65 residues no longer
fractionated with the outer membrane, whereas a variant lacking the N-terminal
anchor domain was not impaired in outer membrane association (94).  Loss of the
final 48 residues rendered TonB inactive and prevented in vivo cross-linking to
FepA, suggesting that residues within this region participate in the interaction
with outer membrane receptors (87).  Finally, a soluble TonB fragment consisting
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of the C-terminal half of TonB was shown to inhibit all TonB-dependent transport
when synthesized in vivo, presumably by out-competing wild type TonB for
binding to outer membrane receptors (75).  Taken together, these data strongly
implicate a region within the C-terminus of TonB in the association with outer
membrane receptors and in energy transduction to these receptors.  The recently
solved crystal structure of the C-terminus of E. coli TonB showed that the region
comprising the final 75 amino acids dimerizes to form a tightly intertwined
cylinder-shaped structure (Fig. 4) (31).  This structural feature of TonB may be
responsible for productive interactions with outer membrane receptors.
3.  INTERACTIONS BETWEEN  LIGAND-BOUND RECEPTORS AND TONB
TonB interacts preferentially with ligand-bound receptors (114), and
insights into how TonB recognizes the ligand-bound state have been gained from
comparisons of liganded and unliganded FhuA.  When FhuA binds its substrate,
there are very few changes in the β-barrel.  In contrast, a periplasmically exposed
region of the plug domain undergoes dramatic conformational shifts, resulting in
the unwinding of helix one (H1) and the displacement of this segment to the
opposite wall of the barrel (108).  It is conceivable that TonB discriminates
between the bound and unbound states by sensing these changes at the
periplasmic face of the receptor.  Because TonB interacts with several different
types of outer membrane receptors involved in high-affinity iron transport, it is
expected that these receptors share a common binding motif for TonB.  Indeed,
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Figure 4.  Stereo ribbon diagram of the C-terminal domain dimer of E. coli TonB.
The diagram depicts two TonB C-terminal domain monomers, A and B,
intertwined to form a dimer.  Monomer A is shown in red and monomer B is
shown in blue.  The arrows represent β-strands, and the cylinders represent α-
helices.  Reprinted from Chang et al., 2001, with permission from the authors and




many TonB-dependent receptors share a short stretch of amino acid homology
near the amino terminus termed the TonB box (80, 133, 136).  In the FhuA
structure, this heptapeptide domain was not resolved; however, the proximity of
the TonB box to the periplasmically exposed region that shifts extensively upon
ligand binding suggests that the TonB box could be involved in the signaling
event (108).  In support of this hypothesis, structural analyses recently
demonstrated that the TonB box of the vitamin B12 receptor BtuB undergoes
significant conformational changes upon substrate binding to the receptor (109).
In FepA, the TonB box is ideally positioned for physical contact with TonB at the
periplasmic face of the receptor, but it is not clear from the structure how this
conformation relates to substrate binding (18).  Both genetic and biochemical
studies have previously implicated the TonB box in a direct interaction with
TonB.  Mutations in the BtuB TonB box that abolish TonB-dependent transport
can be partially suppressed by mutations at residue Q160 in TonB (7).  Site-
directed disulfide cross-linking of cysteine residues engineered into TonB and
BtuB later demonstrated that the region of TonB containing the suppressor
mutations may be in close proximity to the BtuB TonB box (25).  A soluble
pentapeptide corresponding to the first five residues of the TonB box from the
receptor FhuE inhibited transport through a variety of receptors, including FhuA
and FepA, indicating that this peptide interfered with the ability of TonB to bind
to these receptors (171).  Finally, a mutation within the TonB box of FepA that
eliminated enterobactin transport also abolished formaldehyde cross-linking of
TonB to FepA (87).  The data cited above are consistent with a model in which
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TonB directly contacts the TonB box region of the receptor.  However, it seems
clear from studies showing TonB stimulation of ferrichrome transport through a
plugless FhuA variant that TonB makes contacts with residues in the
transmembrane β-barrel as well (13).
C.  Transcriptional regulation of gene expression by iron and Fur
A common feature of genes that participate in iron acquisition is that they
are negatively regulated at the transcriptional level by iron.  This regulation
allows the bacterial cell to carefully coordinate iron uptake with the cell’s iron
requirements.  Negative regulation by iron occurs via the repressor protein Fur.
Fur is a 17 kDa iron-binding protein that, when complexed with Fe2+, blocks
transcription by binding to a conserved operator sequence termed the Fur box
within the promoter region of iron-regulated genes.  In the absence of iron, Fur
cannot bind to the Fur box, and repression is relieved.  The consensus Fur box in
E. coli is a 19 base pair palindrome formed by two, nine base pair (bp) inverted
repeats, separated by one bp: (GATAATGAT)A(ATCATTATC).  Alternatively,
this sequence can be defined as a series of 6 bp repeats.  The Fur box consensus
sequence, when engineered into a non-iron-regulated promoter, was shown to be
sufficient for Fur-mediated repression of the promoter in the presence of iron
(26).  The palindromic nature of the Fur box consensus sequence, combined with
the observation that Fur exists as a dimer in vitro (3), initially suggested a dimer-
palindrome mechanism of binding similar to that employed by other bacterial
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repressor-DNA complexes, such as the DNA-bound lac repressor.  However,
DNA footprinting experiments showed that Fur contacts the DNA on all sides of
the helix in a symmetrical fashion (44), and electron microscopy images
demonstrated Fur multimers wrapped around the DNA helix (92).  These data are
consistent with more than two Fur-DNA contacts, and recent studies using natural
and synthetic Fur binding sites indicate that Fur may bind to a series of at least
three direct or inverted GATAAT repeats throughout the Fur box region in E. coli
(48).
D.  Iron uptake systems and virulence in the host
The importance of iron for growth and virulence of bacterial pathogens in
vivo has been suggested by epidemiological studies showing a direct correlation
between disease progression and iron levels in the host.  Infection by
Mycobacterium tuberculosis elicits a host iron sequestration response, resulting in
anemia in tuberculosis patients.  Treatment of M. tuberculosis infection-induced
anemia with dietary iron supplements was shown to promote the development of
active tuberculosis and increase the risk of death from tuberculosis (45).  Iron
loading conditions, including hemochromatosis and alcoholism, are associated
with a higher incidence of systemic infection with pathogens such as V. vulnificus
and Yersinia pseudotuberculosis, which do not normally cause systemic infections
(177).  In experimental animal models, administering an iron source along with
the bacterial inoculum greatly increases the infectivity and/or virulence of
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V. vulnificus (181), N. gonorrhoeae and N. meningitidis (57), mycobacteria of the
Mycobacterium avium complex (45), and many enteric pathogens (84, 130).
The importance of bacterial iron transport systems for in vivo growth and
pathogenesis has been demonstrated directly by analysis of iron acquisition
mutants.  A S. dysenteriae tonB mutant was shown to be deficient in intracellular
multiplication in cultured cells, and was avirulent in a guinea pig
keratoconjunctivitis model of infection (140).  A Bordetella pertussis tonB mutant
did not multiply in vivo in the mouse respiratory infection model (135).  In a
mouse model of urinary tract infection by the uropathogenic E. coli strain
CFT073, TonB was shown to be required for colonization of the bladder and
kidneys (169).  Other examples of pathogens that require a functional tonB gene
for full virulence in an animal model include P. aeruginosa (163), H. influenzae
(78), and V. cholerae (70, 149).
While studies using tonB mutants serve to illustrate the relevance of high
affinity iron uptake in the host, they do not address the importance of individual
iron transport systems.  In some cases, it is evident that the tonB requirement
correlates directly with the necessity for acquiring a specific iron substrate, not
only within the host, but under all conditions.  Such is the case for heme
auxotrophic organisms such as H. influenzae (78), H. ducreyi (2, 156) and
P. gingigvalis (59, 154), which require exogenous heme for growth.  In other
cases it has been necessary to create defined mutations in individual iron transport
systems in order to assess their role in vivo.  Human volunteers challenged with a
N. gonorrhoeae strain defective in the transferrin receptor complex TbpAB did
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not develop urethritis, demonstrating that transferrin uptake is critical for
establishing infection in the human host (40).  In N. meningitidis, the ability to
acquire iron from hemoglobin via the receptor HmbR is essential for virulence,
and has been proposed to be important for the intravascular stage of
meningococcal bacteremia (159).  Two iron transport systems, Ybt and Yfe, are
required for Y. pestis virulence.  The Ybt system, dedicated to yersiniabactin
synthesis and uptake, is required for infection via the subcutaneous route.  Thus,
the Ybt system may be critical for iron acquisition immediately upon transmission
of Y. pestis to the mammalian host from an infected flea (5).  The Yfe system,
consisting of a periplasmic binding protein-dependent ABC transporter complex,
appears to be important for establishing a systemic infection (6).  In Helicobacter
pylori, the TonB-independent Feo iron transport system is required for virulence
in a mouse model, suggesting that ferrous iron may be the most important source
of iron for this pathogen in vivo (174).
In most cases, pathogens probably rely on multiple systems for iron
acquisition in vivo, and the loss of just one of these systems may not have a
measurable effect on virulence.  In a mouse model of urinary tract infection, E.
coli CFT073 mutants defective in either enterobactin or aerobactin siderophore
synthesis were not impaired in colonization of the kidneys; however, a mutant
defective in both siderophore systems exhibited a measurable decrease in
colonization, suggesting that siderophore-mediated iron acquisition is important
for infection of the kidney (169).  It is likely that other iron transport systems
contribute to colonization as well, since an E. coli CFT073 tonB mutant had an
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even greater deficiency in colonization than that observed for the double
siderophore synthesis mutant (169).  An S. dysenteriae strain defective in both
heme uptake and enterobactin-mediated iron acquisition did not appear to be
starved for iron when growing in cultured cells, suggesting that this pathogen has
alternative means for gaining access to host iron in the intracellular environment
(140).
E.  Life cycle of V. cholerae
The diarrheal disease cholera continues to be a major public health
concern, and epidemics of this disease occur worldwide.  The etiologic agent of
cholera is the bacterium Vibrio cholerae, a Gram negative, motile, curved rod
with a single polar flagellum.  Transmission of V. cholerae to humans is via the
fecal-oral route and occurs primarily via contaminated water supplies.  Within the
host, V. cholerae adapts to the intestinal environment and colonizes efficiently
before being shed in great numbers into the environment.  Outside the human host
V. cholerae can persist in both freshwater and marine aquatic environments, and
the presence of environmental reservoirs for this organism greatly increases the
potential for epidemic outbreaks (reviewed in (41, 51, 83, 146)).  To colonize the
human host, V. cholerae must first survive the acid barrier of the stomach.  The
high infectious dose of V. cholerae is directly related to the sensitivity of this
organism to stomach acids (83).  Bacteria that survive transit through the stomach
use their flagellum to penetrate the mucin layer of the small intestine to reach the
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underlying intestinal epithelium (54).  Colonization of epithelial cells is mediated
by the toxin co-regulated pilus (TCP) (85, 166), and V. cholerae mutants deficient
in TCP production do not cause disease in human volunteers (72, 162).  Infection
with V. cholerae is associated with massive fluid and electrolyte loss, potentially
leading to collapse of the circulatory system and death if left untreated.  The
virulence factor responsible for the profuse diarrhea is cholera toxin (CT), which
causes the activities of intestinal cell ion transporters to be altered, resulting in a
net efflux of ions and water into the lumen of the gut (146).
Coordinate regulation of virulence gene expression within the human host
is achieved through the ToxR/S, TcpP/H, and ToxT regulatory networks.  ToxR
and TcpP are membrane-localized transcription factors which, when associated
with their respective partners ToxS and TcpH, directly regulate the expression of
CT and ToxT in response to environmental stimuli.  ToxT, in turn, activates
transcription of the TCP and CT structural genes (41).  Maximal expression of the
CT genes in vivo occurs after, and is dependent upon, expression of TCP,
suggesting that there is a correlation between colonization of the intestinal
epithelium and efficient CT production (93).  By influencing the ability of
V. cholerae to successfully colonize the host, nutrient acquisition in vivo may also
play a critical role in CT production, and thus in the pathogenesis of this
organism.
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F.  Iron uptake systems in V. cholerae
1.  V. CHOLERAE TONB SYSTEMS
V. cholerae employs a variety of high-affinity iron transport systems, all
of which require a functional TonB, ExbB, ExbD complex (70, 124).  Two sets of
tonB, exbB, exbD genes have been identified in V. cholerae.  The tonB1, exbB1,
and exbD1 genes are located on the smaller (1.07 Mb) replicon, whereas the
tonB2, exbB2, and exbD2 genes are carried by the larger (2.96 Mb) replicon (67,
170).  The two V. cholerae TonB systems exhibit specific as well as overlapping
functions (149), indicating that these systems are not completely redundant.
Further, it was inferred from studies of the function of the V. cholerae tonB genes
in E. coli that the two TonB systems are inherently different.  While the tonB2
system genes can complement an E. coli tonB mutant (124), the TonB1 complex
cannot substitute for the native E. coli TonB complex (68, 124).  The TonB1
complex is, however, able to mediate transport through a V. cholerae receptor in
E. coli (68), suggesting that V. cholerae TonB1 may be highly specific for
V. cholerae receptors.  The presence of two TonB systems has been reported in
other Gram negative pathogens as well, including P. aeruginosa (185), and Vibrio
parahaemolyticus and Vibrio alginolyticus (123).
2.   SIDEROPHORE-MEDIATED IRON ACQUISITION
Under iron-limiting conditions, V. cholerae secretes the siderophore
vibriobactin, a catechol type iron chelator (64).  Vibriobactin is composed of three
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2,3-dihydroxybenzoic acid residues linked to a norspermidine backbone.  Two of
the dihydroxybenzoyl residues are connected to the backbone via oxazoline rings,
while the third is joined directly to norspermidine (64).  The vibriobactin
biosynthetic genes are located in two separate loci, both of which also contain
genes involved in the uptake of iron-bound vibriobactin by the cell (20, 21, 182-
184).  Transport of vibriobactin across the outer membrane occurs via the receptor
ViuA (22, 157).  Disruption of the viuA gene results in a complete defect in
vibriobactin utilization, indicating that ViuA is the only receptor for vibriobactin
in V. cholerae (157).  Either of the two V. cholerae TonB systems mediate
vibriobactin transport, indicating that ViuA is not specific for either TonB (124).
V. cholerae can also use the E. coli catechol siderophore enterobactin (149, 184).
There are two TonB-dependent receptors, IrgA and VctA, involved in
enterobactin transport across the outer membrane (Mey et al., manuscript in
preparation).  In contrast to vibriobactin uptake, enterobactin transport
specifically requires the TonB2 complex (149).  An ABC transporter system
involved in shuttling both vibriobactin and enterobactin across the cytoplasmic
membrane was recently described in V. cholerae, and there is evidence for at least
one more inner membrane system dedicated to catechol transport in this organism
(184).  V. cholerae uses many xenosiderophores besides enterobactin.
V. cholerae can use ferrichrome as an iron source (64); transport of this substrate
occurs via the FhuA receptor (143) and either of the two TonB systems (124).  V.
cholerae also uses schizokinen (produced by Bacillus spp., and by Anabaena
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variabilis) as an iron source (149).  Schizokinen uptake is TonB1-dependent, but
a specific receptor for this substrate has not yet been identified (149).
3.  UTILIZATION OF HEME AND HEMOGLOBIN
V. cholerae can use both heme and hemoglobin as sources of iron (69,
124, 158).  Binding and transport of heme is facilitated by HutA, an iron-
regulated outer membrane protein with many of the conserved features of TonB-
dependent heme receptors (68).  These include an N-terminal TonB box domain, a
FRAP/NPNL motif (11), and at least one of the conserved histidine residues
implicated in heme receptor function (11).  Heme transport in V. cholerae is
absolutely dependent upon the presence of a functional TonB complex (70, 124).
Both V. cholerae TonB systems are capable of mediating heme transport;
however, we recently demonstrated a preferential role for TonB1 in the utilization
of heme and hemoglobin as iron sources (149).  TonB1, the longer of the two
TonBs, is required for transport of heme under high osmolarity conditions.
TonB1 is also required for efficient utilization of hemoglobin as an iron source
(149).  In the same operon as tonB1, exbB1, and exbD1 are genes for the heme-
specific transporters HutB (periplasmic binding protein), and HutC and HutD
(cytoplasmic membrane ABC transporter complex) (124), further implicating the
tonB1 locus in heme utilization.
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4.  REGULATION OF V. CHOLERAE GENE EXPRESSION BY IRON AND FUR
Many genes involved in iron uptake in V. cholerae are negatively
regulated by iron and Fur.  These include the vibriobactin synthesis genes (21,
158), the catechol transport genes (21, 184), and the genes encoding the heme
receptor HutA (68, 164), the vibriobactin receptor ViuA (22, 107), the
ferrichrome receptor FhuA (143), and the enterobactin receptors IrgA (61) and
VctA (Mey et al., manuscript in preparation).  Although a role in iron acquisition
was not definitively established for the El Tor hemolysin gene hlyA, this gene is
also regulated by Fur (158).  V. cholerae Fur shares significant amino acid
identity with E. coli Fur, and can complement an E. coli Fur mutant (105).  The E.
coli Fur protein can also substitute for V. cholerae Fur (158).  As expected, Fur-
binding sequences within the promoter regions of iron-regulated genes in V.
cholerae have significant homology to the E. coli consensus Fur box (19, 21, 22,
61, 68, 183, 184).  Fur-mediated repression of gene expression is not the only
form of iron regulation in V. cholerae.  Two-dimensional PAGE of iron-regulated
proteins from wild type and fur mutant V. cholerae strains have demonstrated
both positive and negative regulation by iron independent of Fur, suggesting that
there are other iron responsive regulatory pathways in this organism (107).
G.  Iron-regulated genes and virulence in V. cholerae
Several studies have addressed the importance of iron transport systems
for V. cholerae virulence.  V. cholerae strains defective in both TonB systems
36
were significantly impaired in the ability to colonize infant mice and cause
disease, indicating that loss of all high affinity uptake systems compromises in
vivo growth (70, 149).  However, it has been more difficult to assess the
contribution of individual iron transport systems to growth and disease production
in vivo.  Mutants defective in the synthesis or transport of vibriobactin were able
to multiply and elicit a diarrheal response in infant mice, suggesting that
vibriobactin-mediated iron acquisition is not required for virulence of V. cholerae
in the mammalian host (151).  A mutant defective in the outer membrane heme
receptor HutA was not significantly compromised in its ability to compete with
the parental strain in a rabbit ileal loop model of infection (164), indicating that
other transport systems may compensate for the loss of HutA-mediated heme
transport in vivo.
Regulation by iron and Fur may also serve to ensure increased expression
of a virulence gene within the iron-limiting environment of the host  (129).  A role
in virulence for the iron-regulated Hly hemolysin was suggested by a study
showing that a strain deficient in hemolysin production exhibited a 100-fold
increase in the LD50 in infant mice (178).  V. cholerae 01 clinical isolates from
Northern Brazil (Amazonia variants) were recently found to possess a cytotoxic
vacuolating activity linked to the Hly hemolysin (34).  The Hly cytotoxin may be
intimately involved in the pathogenesis of the Amazonia variants, since these
strains do not produce any of the other known V. cholerae toxins (35).  The iron-
regulated enterobactin receptor IrgA was proposed to be an important virulence
factor in V. cholerae.  The LD50 of a V. cholerae irgA::TnphoA mutant was 100-
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fold higher than that of the parental strain in an infant mouse model of V. cholerae
infection (62).  However, this study did not demonstrate that the loss of virulence
could be complemented by introduction of the wild type irgA gene.  A different
irgA mutation in the same V. cholerae strain background had no effect on
colonization of infant mice or disease production in these animals, although the
mutation abolished IrgA-mediated enterobactin transport (Mey et al., manuscript
in preparation).  Thus, it is possible that the irgA::TnphoA strain carries additional
mutations that result in attenuation of virulence in the infant mouse model.
H.  Purpose of this dissertation
The first goal of this study was to characterize further the heme utilization
systems in V. cholerae by identifying and characterizing any additional receptors
for heme expressed by this organism.  Identification of all the V. cholerae heme
receptors allowed for more definitive studies of heme receptor characteristics such
as heme substrate specificity and TonB preference, and made it possible to
analyze the role of heme uptake for growth of V. cholerae in vivo.
The second goal of this study was to analyze the regions involved in the
productive interaction between TonB and TonB-dependent receptors.  These
analyses were extended to include an investigation of the specificity exhibited by
V. cholerae TonB1 for a subset of V. cholerae TonB-dependent receptors.
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II.  MATERIALS AND METHODS
A.  Bacterial strains and plasmids
Bacterial strains and plasmids used in this study are described in Table 1.
B.  Media and growth conditions
Bacterial strains were routinely grown at 37°C in Luria (L) broth, in
Bacto® (Difco Laboratories, Detroit, MI) brain heart infusion (BHI) broth, or on L
agar, and maintained at –80°C in tryptic soy broth (TSB, Beckton Dickinson
Microbiology Systems, Beckton Dickinson and Company, Sparks, MD) plus 20%
glycerol.  L broth was prepared by adding 10 g Bacto® tryptone, 5 g Bacto® yeast
extract, and 10 g NaCl per liter ddH2O.  TSB and Bacto
® BHI media were
prepared according to the manufacturer’s instructions.  L agar was prepared by
addition of 15 g Bacto® agar per liter of L broth.  Iron-replete medium was
prepared by the addition of 40 µM ferrous sulfate (FeSO4), and iron-depleted
medium was prepared by the addition of ethylenediamine-di-(o-
hydroxyphenylacetic acid) (EDDA), deferrated by the method of Rogers (142).
Bovine hemin was obtained from Sigma Chemical Company (St. Louis, MO).
Hemoglobin was prepared fresh from whole ovine blood as follows:  red blood
cells were pelleted from 1 ml of whole blood at 5000 × g, and washed repeatedly
with PBS to reduce contamination with free heme.  The washed red cells were
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Table 1. Bacterial strains and plasmids used in this study.
Strain or plasmid Description    Source or reference
Strains
V. cholerae
Lou 15 V. cholerae El Tor strain (150)
CA401 V. cholerae Classical strain (55)
CA401S CA401, StrR (149)
CA40130 Vibriobactin synthesis mutant of CA401 (64)
CA40130N CA40130, NalR This study
DHH11 CA40130, NalR;
defective in both TonB systems (124)
ARM213 DHH11 hutR::kan This study
ARM215 DHH11 hutA::cam This study
ARM219 DHH11 hutA::kan, hutR::cam This study
ARM303 CA40130N ptrB::cam This study
ARM313 CA41030N hutR::cam This study
ARM315 CA40130N hutA::kan This study
ARM316 CA40130N hutA::kan, irgA::cam This study
ARM516 CA40130N irgA::cam, vctA::kan This study
ARM903 CA40130N hutA::kan, ptrB::cam This study
ARM915 CA40130N hutA::kan, hutR::cam This study
ARM930 CA40130N hutA::kan, hutR::cam,
 vhrA::tmp This study
ARM932 CA40130N hutA::kan, hutR::cam,
hasRL9P This study
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AMV527 CA40130N tonB1::kan A. M. Valle
        E. coli
DH5α cloning strain (66)
1017 HB101 entF::Tn5 (43)
SY327 λpir λpir recA56, NalR; host strain for pGP704
Derivatives  (111)
SM10 λpir λpir recA, KanR, mobilizing strain for
pGP704 derivatives (111)
W3110 F– IN(rrnD-rrnE)1 (74)
KP1032 W3110 tonB::kan (90)
KP1032N KP1032, NalR (124)
ARM100 KP1032N entF::cam This study
ARM101 KP1032N fepA::cam This study
ARM107 KP1032N entF::cam, fepAD11Y This study
Plasmids
pACYC184 medium-copy cloning vector, CmR, TcR (30)
pHM5 suicide vector pGP704 carrying sacB;
CbR, SucS (145)
pQF50 promoterless lacZ reporter plasmid; CbR (50)
pWSK29 low-copy cloning vector; CbR (176)
pWKS30 low-copy cloning vector; CbR (176)
pWKS30∆X pWKS30 with the XbaI site disrupted This study
pAGO-cat1 pHM5 carrying vctA::kan Mey et al.,
manuscript
in preparation
pAMC22 pChuA encoding the HutA TonB box
in place of the ChuA TonB box This study
pAMH20 pACYC184 carrying hutA This study
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pAMH21 pAMH20 encoding the FepA TonB box
in place of the HutA TonB box This study
pAMH22 pAMH20 encoding the ChuA TonB box
in place of the HutA TonB box This study
pAML20 pQF50 with the hutA promoter cloned
upstream of lacZ This study
pAML21 pQF50 with the ptrB promoter cloned
upstream of lacZ This study
pAMR12 pWKS30 carrying hutR This study
pAMR14 pACYC184 carrying hutR This study
pAMS1 pHM5 carrying hutA::kan This study
pAMS2 pHM5 carrying hutR::cam This study
pAMS3 pHM5 carrying ptrB::cam This study
pAMS4 pHM5 carrying hasR::tmp This study
pAMS5 pHM5 carrying irgA::cam This study
pAMS6 pHM5 carrying vhrA::tmp This study
pAMS7 pHM5 carrying entF::cam This study
pAMS8 pHM5 carrying fepA::cam This study
pAMT121 pvTonB1X carrying additionally vexbBD1 This study
pAMT111a pWKS30∆X carrying etonBX,
and vexbBD1, hutBCD This study
pAMT112 pAMT12 carrying additionally vhutBCD This study
pAMT113 pAMT112 encoding eTonBX1-119/
vTonB1X122-245 in place of vTonB1X This study
pAMT114 pAMT111 encoding vTonB1X1-121/
eTonBX120-239 in place of eTonBX This study
pAMT121 pAMT111 with an XhoI site introduced into
etonBX at codon 172 (etonBXXh) This study
                                                 
1 V. cholerae genes and gene products are preceded by the letter v, whereas E. coli
genes and gene products are preceded by the letter e.
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pAMT122 pAMT112 with a XhoI site introduced into
vtonB1X at codon 178 (vtonB1XXh) This study
pAMT123 pAMT122 encoding eTonB1XXh1-172/
vTonB1XXh179-245 in place of vTonB1XXh This study
pAMT124 pAMT121 encoding vTonB1XXh1-178/
eTonBXXh173-239 in place of eTonBXXh This study
pAMT131 pAMT111 with an MluI site introduced into
etonBX at codon 208 (etonBXM) This study
pAMT132 pAMT112 with an MluI site introduced into
vtonB1X at codon 214 (vtonB1XM) This study
pAMT133 pAMT132 encoding eTonB1XM1-208/
vTonB1XM215-245 in place of vTonB1XM This study
pAMT134 pAMT131 encoding vTonB1XM1-214/
eTonBXM209-239 in place of eTonBXM This study
pAMT173 pAMT112 encoding eTonBX1-158/
vTonB1X158-245 in place of vTonB1X This study
pAMT183 pAMT112 encoding eTonBX1-158/
vTonB1X165-245 in place of vTonB1X This study
pCHU101 pACYC184 carrying chuA; CmR (168)
pChuA pACYC184 carrying chuA; TcR This study
pChuAT1F pChuA encoding a T1F substitution
in ChuA This study
pEENTF::Cm pWSc-1 (E. E. Wyckoff) carrying
entF::cam A. G. Torres
peTonBX pWKS30∆X carrying E. coli tonB
with an XbaI site introduced at codon 119 This study
pMS101 pBR322 carrying entD, fepA, fes, entF C. F. Earhart
pMTLfepA pMTL24 (29)
carrying fepA This study
pFepA pACYC184 carrying fepA This study
pFepAD11Y pFepA encoding a D11Y substitution
in FepA This study
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pOUT11 pWSK29 V. cholerae exbB2, exbD2, tonB2 (124)
pvTonB1X pWKS30∆X carrying V. cholerae  tonB1
with an XbaI site introduced at codon 121 This study
pv1/eTonBX pWKS30∆X carrying the hybrid
vTonB11-121/eTonB120-239 gene This study
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lysed in an equal volume sterile water, and cellular debris was removed by
centrifugation at 7000 × g.  The supernatant containing hemoglobin was removed,
and the concentration of the hemoglobin preparation was calculated by reading
the absorbance of heme at 572 nm (A572=5.5 at 1 mM heme).  The marine
invertebrate hemoglobin preparations were obtained from A. F. Riggs.  The
preparations were filter-sterilized, and the heme content was calculated as
described above.  Antibiotics were used at the following concentrations for
E. coli:  250 µg of carbenicillin per ml, 250 µg of trimethoprim per ml, 50 µg of
kanamycin per ml, 30 µg of chloramphenicol per ml, 40 µg of nalidixic acid per
ml, and 12.5 µg of tetracycline per ml.  For V. cholerae, one-third of these
concentrations were used, except for nalidixic acid, chloramphenicol, and
tetracycline, which were used at one-fourth the concentrations used for E. coli
strains.
C. Reagents and Enzymes
Unless otherwise indicated, all chemicals were obtained from Sigma
Chemical Company.  Restrictions enzymes, T4 DNA ligase, and DNA
polymerase (Klenow) were obtained from New England Biolabs (Beverly, MA).
Shrimp alkaline phosphatase and Polynucleotide kinase were purchased from
Boehringer Mannheim Corporation (Indianapolis, IN).  Pfu DNA polymerase was
obtained from Stratagene (La Jolla, CA) and Taq DNA polymerase was purchased
45
from Qiagen Inc. (Valencia, CA).  All reagents and enzymes were used according
to instructions supplied by the manufacturer.
D.  Utilization of hemin and siderophores
The ability of V. cholerae and E. coli strains to use various iron sources
was tested in halo assays, in colony size assays and in liquid culture growth
assays as described previously (124, 149).  In halo assays, the indicated strains
were seeded at 106  cells per ml into molten L agar containing EDDA.  Each iron
source to be tested was spotted directly onto the solidified agar, except FeSO4,
which  was soaked into a sterile filter paper disk on the surface of the solidified
agar.  Plates were incubated for 24 hrs at 37°C, then for 24 hrs at room
temperature, and the diameter of each zone of growth was measured.  Colony-size
assays were performed by plating 50-100 cells on L agar supplemented with
FeSO4, with EDDA, or with EDDA plus hemin or hemoglobin.  Colony sizes
were measured after 24 hrs of growth at 37°C.  In broth culture assays, overnight
cultures were diluted to 105 cells per ml  into L broth supplemented with FeSO4,
with EDDA, and with EDDA plus hemin or hemoglobin.  The optical densities
were measured after 18-24 hrs. The concentrations of EDDA and of the iron
sources used in the assays are indicated in each table or figure.  All assays were
repeated at least 3 times.  In order to standardize assay conditions for all strains,
antibiotics were not used in the assays; however, hemin and other iron sources
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provided a positive selective pressure for plasmid retention under low iron
conditions.
E.  Isolation of plasmid and cosmid DNA
Plasmid or cosmid DNA was isolated using the QIAprep Spin Miniprep
kit (Qiagen Inc.).  For plasmid preparations, 3 ml bacterial culture was processed
according to the manufacturer’s instructions, and the plasmid DNA was eluted
from the QIAGEN column using 50 µl sterile double distilled (dd) H2O.  For
cosmid preparations, 5 ml bacterial culture was processed, and the cosmid DNA
was eluted from the QIAGEN column using 100 µl sterile ddH2O at 65°C.
Plasmid and cosmid DNA preparations were stored at –20°C.
F.  Transformation of bacterial strains
1.  TRANSFORMATION OF CACL2-COMPETENT E. COLI CELLS
To prepare CaCl2-competent E. coli cells, an overnight culture was diluted
1:100 into 25 ml fresh L broth and grown to an OD595 of 0.4-0.6.  The culture was
heated at 50°C for 10 minutes to inactivate nucleases, and then chilled on ice for
10 min.  The cells were pelleted by centrifugation at 6000 x g for 10 minutes at
4°C and resuspended in 10 ml ice-cold 100 mM CaCl2.  After a 25 minute
incubation on ice, the cells were harvested by centrifugation at 3000 x g for 10
minutes at 4°C and resuspended in 2.0 ml 0.1 M CaCl2 plus 15% glycerol.  The
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cell suspension was incubated at 4°C overnight and then divided into 0.2 ml
aliquots for transformation.  Any unused aliquots of competent cells were stored
at –80°C.  Competent cells were transformed by adding 100-200 ng plasmid DNA
to 0.2 ml cells.  After incubating for 45 minutes on ice, the cells were heat-
shocked for 2 minutes at 42°C and chilled on ice for 2 minutes.  The cells were
added to 1.6 ml L broth for recovery at 37°C for one hour, and then plated on L
agar supplemented with the appropriate antibiotics.  For iron uptake-deficient
strains, or for strains transformed with a plasmid  carrying a potentially toxic iron-
regulated gene, 40 µM FeSO4 was added to the L agar plates as well.
2.  ELECTROPORATION OF V. CHOLERAE
Electroporation of V. cholerae were carried out as described previously
(124).  Briefly, V. cholerae strains grown overnight in BHI were diluted 1:100
into fresh BHI and grown to an OD650 of 0.4-0.6.  Cells were harvested by
centrifugation at 6000 x g for 10 minutes at 4°C and then resuspended in 20 ml
ice-cold electroporation buffer G (138 mM sucrose, 1 mM Hepes, pH 8).  The
cells were pelleted at 2000 x g for 15 minutes at 4°C and washed again with 20 ml
G buffer.  The cells were resuspended in a final volume of 1 ml G buffer, and 0.4
ml of cells were added to a pre-chilled 0.2 cm Gene Pulser® electroporation
cuvette (Bio-Rad).  For electroporation, 200-500 ng plasmid DNA was added to
the cells just prior to pulsing at 2.4 kV, 25 µF, and 200 Ω, and the cells were
transferred immediately to 1.6 ml BHI and incubated for one hour at 37°C.  The
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cells were then plated to selective media as described above for transformation of
CaCl2-competent E. coli strains.
3.  CONJUGATION
One ml overnight cultures of the donor strain, the recipient strain, and the
mobilizing strain (in the case of tri-parental conjugations) were washed in L broth
and resuspended in 0.1 ml L broth.  A mixture containing 25 µl of each strain was
spotted onto an L agar plate and incubated for 6-8 hours at 37°C.  The cells were
scraped into 1 ml L broth, and transconjugants were obtained by plating the cell
suspension on media selective for the recipient strain and for the transferred
plasmid or cosmid.
G.  Polymerase chain reaction (PCR)
The oligonucleotide primers for PCR were purchased from IDT Inc.
(Coralville, IA).  All primers used in this study are listed in Table 2.  The primers
for PCR-amplification of previously uncharacterized V. cholerae sequences were
designed using the published DNA sequence for V. cholerae El Tor N16961(67).
PCR was performed in a GeneAmp PCR system 2400 (Perkin-Elmer)  as follows:
1 µl bacterial culture (template) was mixed with 250 µM each dNTP, 1 µM each
primer, 2.5 U Pfu polymerase (Stratagene) or Taq polymerase (Qiagen), and the
supplied polymerase reaction buffer (1X final concentrations), in a total volume
of 100 µl.  After a 5 min incubation at 94°C, the reactions underwent 30 cycles of
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internal vtonB1 introduces an XbaI site; results in the
insertion of a Ser residue at amino acid




internal vtonB1 introduces an XbaI site; results in the
insertion of a Ser residue at amino acid












contains a PstI site; contains a Shine-
Dalgarno sequence upstream of exbB1












contains a BamHI site
v1276Xho(+) v8 GCGGGCTCGAGGGC
ACTGTG
internal vtonB1 introduces a XhoI site; results in an
I178L substitution in vTonB1X
v1295Xho(-) v9 CACAGTGCCCTCGA
GCCCGC
internal vtonB1 introduces a XhoI site; results in an
I178L substitution in vTonB1X
v1386Mlu(+) v10 GCTCGACGCGTTGA
AACAGTG
internal vtonB1 introduces an MluI site; results in an




internal vtonB1 introduces an MluI site; results in an




internal vtonB1 no changes in the vtonB1 sequence
v1242(+) v13 GTTCAACCACGTTA
TCCACG











internal etonB introduces an XbaI site; no changes in




internal etonB introduces an XbaI site; no changes in






contains PstI and BamHI sites
e841Xho(+) e5 GCATTGCGCCTCGA
GGGGCAGG
internal etonB introduces a XhoI site; results in an
I172L substitution in eTonBX
e862Xho(-) e6 CCTGCCCCTCGAGG
CGCAATGC
internal etonB introduces a XhoI site; results in an
I172L substitution in eTonBX
e950Mlu(+) e7 AGGTGAAAAACGCG
TTGCGC
internal etonB introduces an MluI site; results in an
M210L substitution in eTonBX
e978Mlu(-) e8 CGCAACGCGTTTTT
CACCTC
internal etonB introduces an MluI site; results in an
M210L substitution in eTonBX
e810(-) e9 ACGGCTTAATGCGC
GTGG









contains an NcoI  site




contains a BamHI site
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hutA 779(-) hutA3 ACTTGACTAGTAAA
TTATTAGC



























replaces the TonB box of HutA with
that of ChuA
hbr 2955(+)RI hutR1 GTGAATTCGCGTTC
TTTCTCACC
upstream of hutR contains an EcoRI site
hrp 5003(-)RI hutR2 TGTGAATTCCATTG
GTAGTTGAGGC
internal hutR contains an EcoRI site




contains a SalI site




contains an EcoRI site
hasR 643(+) hasR1 CGAGGCTTTTGGCT
AAACGG
upstream of hasR














contains an EcoRI site
hrp 777(+)RI ptrB1 CTGGAATTCGACAT
CGACTAAGCC
upstream of ptrB contains an EcoRI site




contains a SalI site




contains an NcoI site









upstream of chuA contains an EcoRV site and a HindIII
site
chuA 780(-) chuA2 CGCGATGATCATAG
CCACGC

























introduces a T1F mutation into ChuA
fepA118(s) fepA1 GCGTAATGAGCTCC
GTGGAAGCG
upstream of fepA contains a SacI site
fepA 1697(-) fepA2 TCATCGCCTAAACC
TTGCG










introduces a D11Y mutation into FepA
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94°C for 30 sec; 50°C for 30 sec; 72°C for 2 min per kb (Pfu) or 1 min per kb
(Taq), followed by a final extension at 72°C for 5 min per kb (Pfu) or 3 min per
kb (Taq).
H.  Plasmid construction
1.  CONSTRUCTION OF PLASMIDS ENCODING HYBRID TONBS
Gene fusions between E. coli tonB and V. cholerae tonB1 were created by
engineering unique restriction sites into the cloned E. coli and V. cholerae tonB1
genes by PCR, and exchanging equivalent tonB fragments.  All clones derived
from PCR fragments were verified by sequencing.  The XbaI, XhoI, and MluI sites
in E. coli tonB and in V. cholerae tonB1 were introduced by overlap extension
PCR using primers described in Table 2 (page 49).  For example, to introduce the
XbaI site into E. coli tonB, primer pairs e1/e2 and e3/e4 were used to create
overlapping fragments containing an XbaI site.  The overlapping PCR products
were gel-purified and added in equimolar amounts as template for a second round
of PCR in which the full-length E.coli tonB gene containing the XbaI site was
created by polymerase extension of the overlapping PCR fragments followed by
amplification of the resulting full-length etonBX gene using primer pair e1/e4.  An
XbaI site was similarly introduced into V. cholerae tonB1 using primers v1/v2 and
v3/v4 to create the overlapping fragments, and primers v1/v4 to amplify the
polymerase-extended final product containing vtonB1X.  The etonB1X and the
vtonB1X PCR products were digested with SalI and BamHI and cloned into
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pWKS30∆X digested with SalI and BamHI to create peTonBX and pvTonB1X,
respectively (Fig. 5A).  The XbaI-BamHI fragments of peTonBX and pvTonB1X
were exchanged to create pe/v1TonBX and pv1/eTonBX (Fig. 5A).
Plasmids carrying native or hybrid tonBX genes in the context of the entire
V. cholerae tonB1 operon were constructed as follows:  A fragment containing the
3’ half of the vtonB1X gene and the vexbBD1, hutBCD genes was amplified by
PCR using primers v3 and v7.  The resulting PCR product was digested with XbaI
and BamHI and cloned into pvTonB1X or peTonBX digested with XbaI and
BamHI to create pAMT112 and pAMT113, respectively (Fig. 5B).  To create
pAMT111 and pAMT114, a fragment containing only the vexbBD1 and hutBCD
genes was amplified using primers v5 and v7.  The PCR product was digested
with PstI and BamHI and cloned into peTonBX or pv/eTonBX digested with PstI
and BamHI, respectively (Fig. 5C).
To construct plasmid series pAMT101-4, the SalI-BamHI fragments from
pAMT111-4 were cloned into pACYC184 digested with SalI and BamHI.
To introduce an XhoI or an MluI site into etonBX, overlapping PCR products were
created with primer sets e1/e6 and e5/v6 (XhoI) or with primer sets e1/e8 and
e7/v6 (MluI) using pAMT101 as the template.  The overlap extension products
were amplified using primer set e1/v6.  An XhoI or an MluI site was similarly
introduced into vtonB1X using primer sets v1/v9 and v8/v6 (XhoI) or v1/v11 and
v10/v6 (MluI) to create overlapping fragments from the pAMT102 template and
primer set v1/v6 to amplify the overlap extension products.  The final PCR
products were digested with SalI and KpnI and cloned into pAMT101
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Figure 5.  Construction of plasmids carrying E. coli and V. cholerae hybrid tonB
genes.
A.  Construction of plasmids peTonBX, pvTonB1X, pe/v1TonBX and
pv1/eTonBX.
B.  Construction of plasmids pAMT112 and pAMT113
C.  Construction of plasmids pAMT111 and pAMT114
D.  Construction of plasmids pAMT121 and pAMT131
E.   Construction of plasmids pAMT122 and pAMT132
F.  Construction of plasmids pAMT123 and pAMT124
G.  Construction of plasmids pAMT133 and pAMT133










(etonB products) or pAMT102 (vtonB1 products) digested with SalI and KpnI  to
yield plasmids pAMT201 (etonBXX), pAMT301 (etonBXM), pAMT202
(vtonB1XX), and pAMT302 (vtonB1XM).
To create plasmid series pAMT121-4, the SalI-BamHI fragments from
pAMT201 and from pAMT202 were first cloned into pWKS30∆X digested with
SalI and BamHI to create pAMT121 (Fig. 5D) and pAMT122 (Fig. 5E),
respectively.  The pWKS30∆X vector backbones contain a XhoI site within the
sequence upstream of the SalI site used to clone in the tonB inserts.  Hybrid tonB
constructs were created by exchanging XhoI fragments between pAMT121 and
pAMT122 to give rise to pAMT123 and pAMT124 (Fig. 5F).
To construct plasmid series pAMT131-4, the SalI-BamHI fragments from
pAMT301 and from pAMT302 were cloned into pWKS30∆XbaI digested with
SalI and BamHI to create pAMT131 (Fig. 5D) and pAMT132 (Fig. 5E),
respectively.  Hybrid tonB constructs were created by exchanging XhoI-MluI
fragments between pAMT131 and pAMT132 to give rise to pAMT133 and
pAMT134 (Fig. 5G).
Hybrid tonB genes were also created by ligating together phosphorylated
E. coli or V. cholerae tonB PCR fragments followed by PCR-amplification of the
desired full-length tonB ligation product.  The hybrid tonB genes contained in
pAMT173 and pAMT183 were created by PCR amplification of a portion of the
etonBX gene using primers e1/e9, and amplification of a portion of the vtonB1X
gene using primers v12/v6 or primers v13/v6.  The gel-purified PCR products
were 5’ phosphorylated and ligated together, and the desired ligation products
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were amplified directly from the ligation reactions using primers e1/v6.  The
amplified hybrid tonB ligation products were gel-purified and digested with SalI
and EcoRI and cloned into pAMT112 digested with SalI and EcoRI to create
pAMT173 and pAMT183 (Fig. 5H).  All clones derived from PCR fragments
were verified by sequencing.
2.  CONSTRUCTION OF PLASMIDS ENCODING OUTER MEMBRANE RECEPTORS
To construct pAMH20, the ~3 kb HindIII-SalI fragment containing the
hutA gene was excised from pHUT3, blunted with Klenow, and cloned into the
ScaI site of pACYC184.  To exchange the TonB box of HutA with that of either
FepA or ChuA, overlapping PCR fragments were created with primer sets
P1/hutA5 and hutA4/hutA3 (FepA TonB box) or P1/hutA7 and hutA6/hutA3
(ChuA TonB box) using pAMH20 as template.  Primer pair P1/hutA3 was used to
amplify the mutant overlap extension products, and the final PCR products were
digested with Bsu36I and SpeI and cloned into pAMH20 digested with Bsu36I
and SpeI to create pAMH21 or pAMH23.  The hybrid receptor genes were
verified by sequencing.    
To construct pAMR12, the hutR gene was amplified from CA40130N by
PCR with Pfu polymerase using primers hutR1 and hutR3.  The PCR fragment
was sequenced to ensure that no mutations were introduced during the
amplification.  To allow expression of the promoterless hutR gene, the 2.2 kb
PCR product was digested with EcoRI and cloned in the same orientation as lacZ
into pWKS30 digested with EcoRI and SmaI to yield pAMR12.  To construct
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pAMR14, the hutR gene was PCR-amplified from CA40130N using Pfu
polymerase and primers hutR1 and hutR4.  The PCR product was digested with
EcoRI and cloned in the orientation of the cam gene in pACYC184 to yield
pAMR14.
To construct pAMR18, a fragment containing irgA and irgB was PCR-
amplified using Pfu polymerase and primers irgBA1 and irgAB2.  The 3.2 kb
PCR product was digested with EcoRI and cloned into the E c oRI site of
pACYC184.  The irgBA insert was moved as an EcoRI fragment to pWKS30 to
yield pCAT121.
To construct pChuA, the ~2.7 kb EcoRV fragment containing the chuA
gene was excised from pCHU101 and cloned into pACYC184 digested with ScaI.
To introduce the HutA TonB box or the T1F mutation into ChuA, primer sets
chuA1/chuA4 and chuA3/chuA2 (HutA TonB box) or chuA1/chuA6 and
chuA5/chuA2 (T1F) were used to amplify overlapping fragments from the
pCHU101 template.  The full-length overlap extension products were amplified
using primers chuA1/chuA2, and the final mutant products were digested with
HpaI and KpnI and ligated into pChuA digested with HpaI and KpnI to create
pAMC23 or pChuAT1F.  The mutations were verified by sequencing.
To construct pFepA, the ~2.5 kb SspI-StuI fragment containing the fepA
gene was excised frompMS101and cloned into pACYC184 cut with ScaI and
PvuII.  The FepAD11Y mutation was introduced into FepA by creating overlapping
mutant fragments using primer sets fepA1/fepA4 and fepA3/fepA2, and pFepA as
template.  After overlap extension, the full-length fragment containing the
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mutation was amplified using primers fepA1/fepA2.  The PCR product was
digested with Bsu36I and EcoRI and cloned into pFepA digested with Bsu36I and
EcoRI to create pFepAD11Y.  The mutation was verified by sequencing.
3.  CONSTRUCTION OF SUICIDE PLASMIDS FOR ALLELIC EXCHANGE IN
E. COLI
To construct pAMS7, the ~3.8 kb SalI-EcoRV fragment containing
entF::cam was excised from pEENTF::Cm and cloned into pHM5 digested with
SalI and EcoRV.
To disrupt the fepA gene, a cam cassette was inserted as a KpnI fragment
into the KpnI site within fepA in pMTLfepA.  The fepA::cam insert was excised
as a SalI fragment and cloned into pHM5 digested with SalI to create pAMS8.
4.  CONSTRUCTION OF SUICIDE PLASMIDS FOR ALLELIC EXCHANGE IN
V. CHOLERAE
To create an insertional mutation in hutA, the kanamycin resistance
cassette from pUC4K (Pharmacia) was cloned as a PstI fragment into the NsiI site
in the hutA gene on pHUT3.  The disrupted hutA gene was subcloned as a HincII
fragment into the EcoRV site of pHM5 to create pAMS1.
To disrupt hutR, a fragment containing ptrB and hutR was amplified by
PCR with Pfu polymerase using primers ptrB1 and hutR2.  The 4.2 kb PCR
fragment was digested with EcoRI and cloned into the EcoRI site of pACYC184
to yield pAMR1.  The EcoRV-XbaI fragment of pAMR1 containing hutR was
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then subcloned into the E c oRV and XbaI-digested pHM5, and the
chloramphenicol resistance cassette (cam) from PMTLcam (E. E. Wyckoff) was
inserted into the NruI site in hutR to create pAMS2.
To construct a polar insertion in ptrB, a 2.3 kb fragment containing ptrB
was PCR-amplified with Taq polymerase using primers ptrB1 and ptrB2.  The
PCR product was digested with EcoRI and SalI and cloned into pWKS30 digested
with EcoRI and SalI to yield pAMP1.  The ptrB gene was disrupted by insertion
of the cam cassette into the Klenow-blunted NheI site in ptrB.  The ptrB::cam
fragment was excised using SalI and SmaI and inserted into pHM5 digested with
SalI and EcoRV to create pAMS3.
To create a mutation in hasR, a fragment containing hasR was PCR-
amplified from the V. cholerae El Tor strain Lou15 using Taq polymerase and
primers hasR1 and hasR2.  The PCR fragment was digested with BamHI and
EcoRI, and cloned into BamHI and EcoRI-digested pWKS30 to yield pAMR16.
The hasR gene was disrupted by inserting a trimethoprim (tmp) cassette (E. E.
Wyckoff) into the MscI site.  The hasR::tmp fragment was excised using XhoI and
SpeI, and cloned into pHM5 cut with SalI and XbaI to yield pAMS4.  During the
allelic exchange procedure it was discovered that exchanging just the 5’ end of
the hasR gene in ARM915 with the equivalent region from hasR in pAMS4
completely abolished hemin utilization in the resulting strain, ARM932.  It was
determined by sequence analysis that the hasR allele present in pAMS4 and in
ARM932, but not in ARM915, contained a PCR-introduced mutation that causes
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an L9P substitution within the putative signal sequence of HasR.  This
substitution most likely interferes with export of HasR to the outer membrane.
To inactivate irgA, the cam cassette was inserted as a SmaI fragment into
the SmaI site of the irgA gene carried on pAMR18.  The irgA::cam insert was
moved as a Klenow-blunted ClaI fragment into pHM5 digested with EcoRV to
yield pAMS5.
The construct pAMS6 carrying the disrupted vhrA gene, the ~2.3 kb HpaI-
SalI   fragment from pAMR30 was cloned into pHM5 digested with EcoRV and
SalI, and the tmp cassette was inserted as a SmaI fragment into the Klenow-
blunted NcoI site within vhrA.
5.  CONSTRUCTION OF PROMOTER FUSION PLASMIDS
The hutA promoter region was PCR-amplified from CA40130N with Pfu
polymerase using primers hutA1 and hutA2; the ptrB promoter region was
similarly amplified using primers ptrB3 and ptrB4.  The PCR fragments were
digested with NcoI and BamHI and cloned into pQF50 digested with NcoI and
BamHI to create the hutA-lacZ (pAMP20) and the ptrB-lacZ (pAMP21)
transcriptional fusions.
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I.  Construction of chromosomal mutations in E. coli and
V. cholerae genes
Cloned E. coli or V. cholerae genes were disrupted by insertion of an
antibiotic resistance cassette, and transferred to the λpir-dependent suicide vector
pHM5, which also contains the sacB gene conferring sensitivity to sucrose.  The
resulting suicide plasmids were transferred by mating from E. coli SM10λpir into
the E. coli or V. cholerae recipient strain, and transconjugants were selected as
described above.  After growth overnight, E. coli transconjugants were plated
directly on selective media containing 5% (w/v) sucrose, whereas V. cholerae
transconjugants were diluted 1:100 into L broth containing 5% (w/v) sucrose and
grown for 3-4 hours, and then plated on selective media containing 10% (w/v)
sucrose.  Because V. cholerae strains carrying the sacB gene encoded by pHM5
are not lysed immediately when grown on sucrose, it was necessary to distinguish
sucrose resistant V. cholerae colonies by colony morphology:  sucrose-resistant
colonies appeared clear and flat, whereas sucrose-sensitive colonies appeared
opaque and globular and underwent lysis after approximately 24 hours.  E. coli or
V. cholerae colonies that were resistant to sucrose and to the antibiotic specified
by the marked allele were screened for sensitivity to carbenicillin to verify loss of
the suicide plasmid from the strain.  The allelic exchange mutants were analyzed
by PCR using primers annealing to chromosomal sequences outside of the region
included in the mutagenic suicide construct.
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J.  Sequence analysis
DNA sequencing was performed by the University of Texas Institute for
Cellular and Molecular Biology DNA Core Facility using an ABI Prism 377 DNA
sequencer.  Analysis of DNA sequences, including ORF analysis, restriction
mapping and ClustalW alignments, was carried out using MacVector™ 7.0.
Protein sequence alignments were also carried out using the CLUSTAL-W program
from within MacVector™ 7.0.  Signal peptide predictions for putative
periplasmic, outer membrane or exported proteins were made using the SignalP
program on the SignalP server at www.cbs.dtu.dk/services/SignalP.  Secondary
structure predictions for amino acid sequences based on similarity to solved
crystal structures were carried out using the 3D-PSSM program on the 3D-PSSM
Web Server V 2.6.0 at www.bmm.icnet.uk/~3dpssm.  Protein sequence
comparisons to the COG database (NCBI) were performed using the COGnitor
search engine at www.ncbi.nlm.nih.gov/COG/xognitor.html.  The BLASTX or
BLASTP programs were used to search for homologous DNA or amino acid
sequences in the Genbank database (NCBI, at www.ncbi.nlm.nih.gov/BLAST/)
and the V. cholerae genome database (TIGR, at http://tigrblast.tigr.org/cmr-
blast/index.cgi?database=GVC.seq).
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K.  β-galactosidase assays
Strains were grown to mid-log phase in iron-replete media containing 40
µM FeSO4, or in iron-depleted media containing 300 µg per ml EDDA.  The
procedure described by Miller (110) was used to quantify β-galactosidase activity
in the cells.  Briefly, 1 ml bacterial cultures were pelleted and resuspended in 1 ml
β-galactosidase assay buffer (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl,
10 mM Mg SO4
.7H2O; pH adjusted to 7.0; 40 µl 1 M DTT added fresh per 100 ml
assay buffer), and the OD660 was measured.  The cells suspensions were diluted
1:10 into 1 ml of assay buffer in a 100 x 13 mm glass tube.  To permeabilize the
cells, 40 µl 0.1%  SDS and 20 µl chloroform were added to the cells, and the
tubes were vortexed for 5 seconds and then incubated for 10 minutes at  room
temperature.  To start the assay, 0.2 ml ONPG was added to each tube, and the
time lapsed until yellow color was clearly visible was recorded.  The assay was
stopped by adding 0.5 ml 1 M Na2CO3 per tube.  The OD420 and OD550 of each
reaction was measured, and the following formula was used to calculate β-
galactosidase activity:  Units = 1000 x [OD420 – (1.75 x OD550)]/t x V x OD660,
where t = time (minutes), and V = volume (ml) of cell suspension added to each
assay tube.
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L.  Cell fractionation
Overnight cultures were diluted 1:100 into 50 ml L broth containing 10 µg
per ml EDDA  to induce expression of iron-regulated genes.  The diluted cultures
were grown to an OD of 0.5 and harvested by centrifugation at 7000 x g for 10
minutes at 4°C.  After resuspension in 3 ml Hepes buffer (10 mM, pH 7.4), the
cells were frozen at –80°C.  CompleteTM EDTA-Free protease inhibitor cocktail
(Roche Diagnostics, Mannheim, Germany) was added after thawing, and the cells
were broken by passage twice through a FRENCH® pressure cell (SLM-
AMINCO®, Thermo Spectronic, Rochester, NY) at 12,000 psi.  Unbroken cells
were pelleted at 8000 x g for 20 minutes at 4°C, and the broken cell extract was
centrifuged for 45 minutes at 100,000 × g at 12°C to collect the total membrane
fraction (77).  The supernatant containing the cytosolic fraction was added to
Laemmli solubilization buffer (86) and frozen at  –20°C.  The total membrane
fraction was washed twice with 1 ml sterile ddH2O using a blunt needle, and
resuspended in a final volume of 150 µl sterile ddH2O.  The Sarkosyl (N-
lauroylsarcosine)-insoluble outer membrane fraction was isolated by the method
of Filip et al. (53).  This method was used previously to obtain outer membrane
preparations from V. cholerae with less than 5% inner membrane contamination
(150).  Sarkosyl (0.5% final concentration) was added to the total membrane
suspension, and after incubating for 20 minutes at room temperature the Sarkosyl-
treated membranes were centrifuged for 45 minutes at 100,000 × g at 12°C.  The
supernatant containing the inner membrane fraction was collected and frozen at
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–20°C in Laemmli solubilization buffer (86).  The pellet containing the Sarkosyl-
insoluble outer membrane fraction was washed in 1 ml sterile ddH2O containing
1% Sarkosyl, and centrifuged at 100,000 × g for 45 minutes at 12°C.  The outer
membrane fraction was resuspended in a final volume of 0.2 ml.  Membrane
fractions from equivalent numbers of cells (4 x 108) were resolved by SDS- 7.5%
PAGE, and the proteins were visualized by Coomassie Brilliant Blue staining.
M.  Sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE)
Proteins from membrane preparations were analyzed by SDS- 7.5% PAGE
to resolve proteins in the 70-80 kDa range.  The 7.5% resolving and 4% stacking
gels were prepared using a 30% Acrylamide/Bis solution (Bio-Rad Laboratories,
Hercules, CA) according to the manufacturer’s instructions, and the gels were cast
using the Mini-PROTEAN® II gel casting system (Bio-Rad).  Protein samples and
low range SDS-PAGE standards (Bio-Rad) were boiled for 3 minutes in sample
buffer and loaded onto the gels.  Gels were electrophoresed in a Mini-
PROTEAN® II cell (Bio-Rad) in SDS-PAGE running buffer (25 mM Tris base,
192 mM glycine, 0.1% SDS, pH 8.3) at 20 mA through the stacking gel and 40
mA through the resolving gel.  To visualize proteins, the gels were Coomassie-
stained (0.1% R-250 Brilliant Blue, 50% MeOH, 10% acetic acid) for 30 minutes
and then destained in 7% acetic acid and 5% MeOH for 24 hours.  Gels were
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dried between 2 sheets of cellophane using an Easy Breeze Drying Frame from
Hoefer Scientific Instruments (San Francisco, CA).
N.  In vivo competition assays
In vivo competition assays were performed by a protocol modified from
Taylor et al. (166).  Five-day old pre-starved BALB/c mice were inoculated
intragastrically using a 1cc tuberculin syringe with a 1 inch 23 gage needle fitted
with 2 cm of intramedic PE-50 polyethylene tubing (inner diameter 0.58 mm;
outer diameter 0.965 mm).  Each inoculum consisted of 50 µl saline containing
0.5% sucrose, 0.02% Evan’s Blue dye, and 5 x 105 cfu of each strain grown to
mid-log phase under iron-limiting conditions.  The mice were sacrificed after 24
hrs.  Mice that had been properly inoculated exhibited dye accumulation in the
large intestine and colon.  The small intestine and the upper part of the large
intestine were isolated and homogenized in saline using a Dounce homogenizer.
Serial dilutions of the homogenate were plated on selective media to determine
the viable counts for each strain.  The output ratio of the competing strains was
normalized to the input ratio to determine the competitive index.
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III.  RESULTS
A.  Identification and characterization of two additional TonB-
dependent heme receptors in V. cholerae
1.  CHARACTERIZATION OF A V. CHOLERAE HUTA MUTANT
To further characterize the heme uptake system of V. cholerae, a mutation
in the gene encoding the heme receptor HutA was generated in a vibriobactin
(Vib)-synthesis mutant, CA40130N.  The Vib- strain was chosen in order to
eliminate background growth due to vibriobactin-mediated iron uptake in iron-
limited media.  The growth of the hutA mutant ARM315 was tested in a colony
size assay as described previously [Occhino, 1998 #490]; this assay yields the
most reproducible results when measuring subtle growth differences.  The hutA
mutant had only a slight defect in the ability to use hemin as the sole source of
iron, compared to its Vib- parental strain.  This defect was remedied by supplying
hutA on a plasmid (Table 3).  The hutA mutation had no effect on transport of
other TonB-dependent substrates, including ferrichrome and vibriobactin (data
not shown).  These data suggest that there is a HutA-independent mechanism for
transport of heme across the outer membrane in V. cholerae.  Because our earlier
studies showed that TonB-defective strains of V. cholerae do not use hemin as an
iron source (70, 124), this additional heme uptake system in V. cholerae must
involve one or more TonB-dependent receptors.
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Table 3. HutA- and HutR-dependent hemin utilization in V. cholerae.
Average colony size (mm) after 24 hrs on L agar
containing:a
Strain Relevant FeSO4 EDDA EDDA + hemin
CA40130N parent 1.9 NG 1.3
ARM315c HutA- 1.8 NG 1.0
 e
ARM315/pAMH20 HutA+ 1.6 NG 1.3
ARM313 HutR- 1.8 NG 1.3
ARM915d HutA-, HutR- 1.9 NG < 0.2
 e
ARM915/pAMR12 HutA-, HutR+ 1.8 NG 1.4
ARM915/pAMH20 HutA+, HutR- 1.8 NG 1.2
a.  The indicated strains were plated on L agar supplemented with 40 µΜ FeSO4, with 100 µg EDDA per ml, or with EDDA and
5 µΜ hemin.  Each number represents the mean diameter of 10 well-isolated colonies (> 5 mm apart).  The standard deviation for each
data set was less than 0.15 mm for growth on L agar + FeSO4, and less than 0.1 mm for growth on iron-depleted media supplemented
with hemin.  NG = No growth.
b.  All strains are derived from CA40130N and thus are Vib-.
c.  ARM315 carrying the vector pACYC184 had the same average colony size as ARM315.
d.  ARM915 carrying the vectors pWKS30 or pACYC184 had the same average colony size as ARM915.
e.  P < 0.001 (Student’s t test) compared to CA40130N.   
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2.  IDENTIFICATION OF A PUTATIVE SECOND RECEPTOR FOR HEME IN
V. CHOLERAE
A BLAST search of the TIGR V. cholerae genome database using the
HutA amino acid sequence identified several uncharacterized, putative TonB-
dependent receptors.  One of these, VCA0064, showed significant homology to V.
cholerae HutA (68) (41% similarity; 25% identity) and to V. vulnificus HupA
(106) (39% similarity; 22% identity), as well as to other heme receptors.  We
named this putative heme receptor HutR.  HutR has a calculated mass of 80.5 kDa
in the unprocessed form.  Cleavage of the putative N-terminal signal sequence
(120) would yield a 78.5 kDa mature protein with a calculated pI of 5.1.
The hutR gene is located on the smaller of the two V. cholerae replicons,
and is the second open reading frame (ORF) in a predicted five-member operon
that includes a type II protease gene, ptrB, as well as three hypothetical ORFs of
unknown function (67) (Fig. 6a).  A potential Fur box is present upstream of the
putative transcriptional start site for this operon, indicating that these genes may
be iron regulated (Fig. 6b).  No promoters between ptrB and hutR were predicted
from analysis of the DNA sequence.  A potential Rho-independent transcription
terminator is located downstream of the last ORF in the hutR operon.
Sequence analysis revealed that HutR contains many of the conserved
features of TonB-dependent outer membrane receptors, including a TonB box
similar to the V. cholerae HutA and V. vulnificus HupA TonB boxes (Fig. 6c).
Significant homology to outer membrane receptors was also found at the C-
terminus of HutR:  HutR contains the terminal phenylalanine residue thought to
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Figure 6.  Sequence analysis of the hutR locus.
A.  The thick shaded arrows delineate the open reading frames in the potential
five-member operon containing hutR.  The thin right-angle arrow shows the
location of the putative promoter for this operon, and a potential transcriptional
terminator is indicated by a stem-loop structure downstream of ORF VCA0067.
B .  Analysis of the predicted promoter region for the hutR operon shows a
putative Fur box sequence (boxed).  The translational start site for ptrB is
indicated by the arrow, and the N-terminal residues of PtrB are labeled using the
single-letter code.
C.  HutR, HutA and HupA were aligned using CLUSTAL-W.  The numbers refer
to amino acid position in the unprocessed protein.  The arrowhead indicates the
predicted N-terminal signal sequence cleavage site for HutR.   Conserved residues
are marked by an asterisk, and similar residues are denoted by a period. The TonB
box is delineated by the horizontal bar.  The FRAP and NPNL motifs are boxed,




be required for proper incorporation into the outer membrane (161), as well as the
invariant arginine residue at position 11 from the C-terminus (Fig. 6c).  HutR also
contains motifs conserved among outer membrane receptors specific for heme and
hemoglobin, including a complete FRAP box, a partial NPNL box, and one of the
highly conserved histidine residues implicated in heme receptor function (Fig. 6c)
(11).
3.  CHARACTERIZATION OF A V. CHOLERAE HUTA, HUTR MUTANT
In order to ascertain whether HutR functions as a heme receptor in V.
cholerae, a hutR single mutant and a hutA, hutR double mutant were generated by
allelic exchange in the Vib- background.  In a colony size assay, the hutR single
mutant ARM313 used hemin iron as efficiently as the parental strain CA40130N
(Table 3); however, the hutA, hutR double mutant ARM915 was significantly
impaired in hemin utilization compared to both the parental strain and to the hutA
single mutant ARM315 (Table 3).  These data suggest that both HutA and HutR
participate in heme transport in V. cholerae.  To verify that the transport defect
observed for the hutA, hutR mutant is dependent upon loss of hutR expression,
and not due in part to polar effects on downstream genes, ARM915 was
transformed with pAMR12, which contains only the hutR gene.  Expression of
hutR from pAMR12 complemented the hemin transport deficiency of the hutA,
hutR mutant ARM915 (Table 3); therefore, the phenotype of ARM915 cannot be
attributed to the disruption of downstream genes.  These data confirm that hutR
encodes a functional heme receptor in V. cholerae.  A plasmid carrying hutA,
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pAMH20, also restored hemin transport to the hutA, hutR mutant (Table 3).   In
both cases, the complemented strains used hemin as efficiently as the parental
strain, despite lacking one of the heme receptors.  Thus, the presence of multiple
copies of one receptor gene on a complementing plasmid appeared to compensate
for the loss of the other receptor gene, showing that both receptors are capable of
efficient hemin transport under the conditions tested.
4.  IDENTIFICATION OF AN IRON-REGULATED PROMOTER FOR HUTR
Sequence analysis predicted that the hutR and ptrB genes may be co-
transcribed.  To determine whether hutR expression is controlled by the promoter
upstream of ptrB, or whether an internal promoter exists for hutR, an insertion
mutation in ptrB was constructed in the hutA::kan background.  The resulting
strain ARM903 was significantly impaired in growth on media containing hemin
as the sole iron source, and thus it behaved like the hutA, hutR double mutant
ARM915 (Fig. 7).  Plasmid-encoded HutR restored hemin utilization to the hutA,
ptrB mutant, showing that the defect in hemin uptake was due to loss of hutR
expression rather than to the disruption of ptrB (Fig. 7).  These data suggest that
ptrB and hutR are co-transcribed, and that PtrB is not required for utilization of
hemin under the conditions tested.
The promoter region upstream of ptrB contains a potential Fur box,
suggesting that the operon containing ptrB and hutR is iron-regulated.  To analyze
the regulation of these genes, the ptrB promoter was cloned upstream of the
promoterless lacZ gene in pQF50 to create a transcriptional fusion.  As a control,
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Figure 7.  The hutR and ptrB genes are co-transcribed.
The right-angled arrow indicates the location of the putative promoter for the hutR
operon.  A partial restriction map of the hutR region shows the sites of the polar
cam cassette insertions.  The ability to use hemin as an iron source was measured
by plating the indicated strains on L agar containing 100 µg EDDA ml-1 and 5 µM
hemin.  Each number in the right hand column represents the mean diameter of 10
well-isolated colonies (> 5 mm apart) after 24 hrs.  The standard deviation for
each data set was less than 0.1 mm.
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a transcriptional fusion between the iron-regulated hutA promoter (69) and lacZ
was created as well.  V. cholerae strains carrying these constructs were grown to
mid-log phase under high or low iron conditions, and the expression of lacZ was
measured as β-galactosidase activity.  Both the hutA and ptrB promoters were
strongly induced in the absence of iron, and the level of induction was comparable
for the two promoters (Fig. 8).
5.  CELLULAR LOCALIZATION OF HUTR
The hutR gene encodes a potential N-terminal signal sequence, consistent with
export of HutR to the outer membrane.  To determine the subcellular localization
of HutR, cellular fractions were prepared from iron-limited CA40130N (Vib-
parental strain; Fig. 9, lanes 1 and 5), ARM915 (hutA, hutR mutant; lanes 2 and 6),
and ARM915 carrying either hutR (lanes 3 and 7) or hutA (lanes 4 and 8) on a
plasmid.  The 78.5 kDa mature HutR protein was present in the total membrane
fraction of cells expressing hutR from a plasmid, but not in the cytosolic fraction
(data not shown).  Separation of the inner and outer membranes by Sarkosyl
extraction showed that HutR is associated with the outer membrane (lane 7).
Plasmid-encoded 75.0 kDa mature HutA was similarly detected in the total
membrane and outer membrane fractions (lanes 4 and 8), consistent with earlier
studies showing that HutA is present in the outer membrane (69).  Interestingly,
HutA, but not HutR, was visible in the outer membrane fraction isolated from the
parental strain CA40130N (lane 5), indicating that the levels of HutA exceed the
levels of HutR in the outer membrane of wild type cells in low iron conditions.
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Figure 8.  Regulation of hutA-lacZ (pAML20) and ptrB-lacZ (pAML21)
transcriptional fusions by iron.
Strains were grown to mid-log phase in iron-replete media (+ FeSO4) or in iron-
depleted media (+ EDDA), and β-galactosidase activity was measured.  The data
represent the averages of three independent experiments.  Standard deviations are
indicated by the error bars.
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Figure 9.  Cellular localization of HutR and HutA.
Total membrane and outer membrane fractions were isolated from V. cholerae
CA40130N (Vib- parental strain; lanes 1, 5), ARM915 (HutA-/HutR-; lanes 2, 6),
ARM915/pAMR12 (expressing plasmid-encoded HutR; lanes 3, 7), and
ARM915/pAMH20 (expressing plasmid-encoded HutA; lanes 4, 8), grown in low
iron conditions.  Membrane fractions from equivalent numbers of cells (4 x 108)
were resuspended in Laemmli buffer, and the proteins were resolved by SDS-
7.5% PAGE and visualized by Coomassie Brilliant Blue staining.
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6.  ANALYSIS OF HEMOGLOBIN UTILIZATION IN V. CHOLERAE
V. cholerae growing within the human host is not likely to encounter free
heme, but rather host heme-containing proteins such as hemoglobin.  We had
observed earlier that the ability to use hemoglobin as an iron source specifically
requires the TonB1 system (149).  This TonB-dependence may reflect the
preferential use of a particular receptor for utilization of hemoglobin.  To address
this issue, single mutants in hutA (ARM315) or hutR (ARM313) were compared
with respect to growth in media containing hemin or hemoglobin as the sole
source of iron (Table 4 and Fig. 10).  The mutation in hutR had no effect on the
ability to use either hemin or hemoglobin, suggesting that HutR does not have a
specific function in hemin or hemoglobin utilization that cannot be carried out by
HutA or some other protein under these conditions.  The hutA mutant, however,
was significantly impaired in growth using hemoglobin as the iron source.  The
defect observed for the hutA mutant was comparable to the defect observed for a
tonB1 mutant in the same background (AMV527), suggesting that the TonB1-
HutA pair plays a critical role in the ability to access heme-iron from hemoglobin
(Table 4 and Fig. 10).
Utilization of hemoglobin as an iron source likely requires the release of
heme from hemoglobin prior to transport of heme into the cell.  Indeed,
CA40130N had a slower growth rate in media containing hemoglobin than in
media containing free hemin (Fig. 10).  These data suggest that either the affinity
for hemoglobin is lower than for free heme, or that release of the heme moiety is
the limiting step in the process of hemoglobin utilization.  To test whether the
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Table 4.  Hemoglobin utilization by V. cholerae.
Average colony size (mm) after 24 hrs on L agar containing: a
Strain Relevant
phenotype b




CA40130N parent 1.8 NG 1.6 0.8
ARM303 PtrB-, HutR- 1.9 NG 1.7 0.8
ARM313 HutR- 1.9 NG 1.6 0.8
ARM315 HutA- 1.9 NG 1.3
 c <0.2 d
ARM915 HutA-, HutR- 1.9 NG <0.2
 c NG
AMV527 TonB1- 1.9 NG 0.9 c <0.1 d
a.  The indicated strains were plated on L agar supplemented with 40 µΜ FeSO4, with 50 µg EDDA per ml (in this experiment it was
necessary to reduce the EDDA concentration from 100 to 50 µg per ml for optimal growth using hemoglobin as the sole iron source), or
with EDDA and 5 µΜ hemin or hemoglobin.  Each number represents the mean diameter of 10 well-isolated colonies (> 5 mm apart).
The standard deviation for each data set was less than 0.15 mm for growth on L agar + FeSO4, and less than 0.1 mm for growth on iron-
depleted media supplemented with hemin.  NG = No growth.
b.  All strains are derived from CA40130N and thus are Vib-.
c.  P < 0.001 (Student’s t test) compared to CA40130N on EDDA + hemin.
d.  P < 0.001 (Student’s t test) compared to CA40130N on EDDA + hemoglobin.
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Figure 10.  Role of HutA and TonB1 in utilization of hemin or hemoglobin as the
sole iron source.
Strains were inoculated into L broth containing 75 µg EDDA per ml, and 2.5 µM
hemin or hemoglobin.  The optical density was measured at the indicated time
points.  Growth in iron-replete media was comparable for all the strains tested, and
none of the strains grew in iron-depleted media (data not shown).  ( ) CA40130N
(Vib- parental strain), hemin; ( ) CA40130N (Vib- parental strain), hemoglobin;
(∆) ARM315 (HutA-), hemin; ( ) ARM315 (HutA-), hemoglobin; ( ) AMV527



























putative protease encoded by the ptrB gene upstream of hutR plays a role in heme
acquisition from hemoglobin, a strain carrying an insertion in ptrB, ARM303, was
tested for ability to grow on solid media containing hemoglobin as the sole source
of iron (Table 4).  The ptrB mutation did not adversely affect hemoglobin
utilization, indicating that either PtrB is not involved in hemoglobin degradation, or
V. cholerae encodes additional proteins that can facilitate the release of heme from
hemoglobin prior to uptake by the cell.  The lack of an effect of the ptrB mutation
on hemin or hemoglobin utilization was confirmed in a growth curve experiment in
liquid medium as well as in a halo assay (data not shown).
7.  IDENTIFICATION OF A THIRD HEME RECEPTOR IN V. CHOLERAE
Although the hutA, hutR double mutant was significantly impaired in
hemin utilization, producing only a pin-point colony in a colony size assay
(Table 3, page 79), a small amount of growth around hemin was clearly detectable
in halo assays (Table 5).  We were interested in determining whether this residual
growth might be due to a third heme transport mechanism in V. cholerae.  A
BLAST search of the TIGR V. cholerae protein database using HutA as the query
sequence identified a third candidate heme receptor, VCA0625.  We named this
putative heme receptor HasR because of its overall similarity to the HasR
hemophore receptors from P. aeruginosa (125) (32% similarity) and from S.
marcescens (60) (31% similarity).  A mutation in the hasR gene was created by
allelic exchange in the hutA, hutR mutant to yield ARM932.  Unlike the hutA,
hutR double mutant ARM915, the triple mutant ARM932 was completely
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Table 5.  HasR-dependent hemin utilization in V. cholerae.
Zone of growth (mm) after 48 hoursa
Strain Relevant Phenotypeb FeSO4 Hemin Vibriobactin
c
CA40130N parent 23 15 32
ARM915 HutA-, HutR- 23 7 30
ARM932 HutA-, HutR-, HasR- 25 NG 31
a.  The indicated strains were seeded at 106 cells per ml into molten L agar containing 100 µg EDDA per ml.  Iron sources were
spotted onto the solidified agar as follows:  20 µl 10 mM FeSO4; 5 µl CA401 overnight culture (vibriobactin); 5 µl 50 µM
hemin.  NG = No growth.  Plates were incubated for 24 hrs at 37°C, then for 24 hrs at room temperature, and the diameter
of each zone of growth was measured.  The assays were repeated at least 3 times.  Although the relative differences between
strains were consistent between experiments, the absolute values for each strain varied due to subtle changes in the media
and assay conditions, and thus only one representative experiment is shown.
b.  All strains are derived from CA40130N and thus are Vib-.
c.  Vibriobactin utilization shows proper TonB function.
98
deficient in hemin utilization, and we conclude that HasR is the third, and likely
final, heme receptor in V. cholerae (Table 5).  HasR-mediated growth required a
relatively high local concentration of hemin, such as that provided by spotting the
hemin directly onto the surface in a halo assay.  Thus, HasR may be a less
efficient heme transporter than either HutA or HutR, or may be expressed at lower
levels under the conditions used for the hemin utilization assays.
8.  TONB SPECIFICITIES OF THE THREE V. CHOLERAE HEME RECEPTORS
Our earlier studies showed that efficient heme transport through HutA in
E. coli requires the V. cholerae TonB1 system (68, 124).  In contrast, the V.
cholerae TonB2 system failed to promote hemin uptake via HutA in E. coli (data
not shown).  These data suggest that HutA may have a strong preference for the
TonB1 system.  Similar results were obtained when hutR was expressed in E. coli
(data not shown).  To establish whether the observed dependence of HutA and
HutR on the TonB1 system in E. coli reflects a true specificity for the TonB1
system, a series of receptor mutants was created in DHH11, a TonB-deficient
derivative of V. cholerae CA40130.  DHH11 was unable to use any of the TonB-
dependent substrates tested unless supplied with a set of tonB system genes.  We
had shown earlier that either V. cholerae TonB system facilitates vibriobactin
transport; however, only the TonB2 system promotes enterobactin transport (149).
These two iron sources were therefore included to demonstrate proper function of
the TonB system expressed in each strain tested.  The TonB specificities of HutA
and HutR were investigated by constructing a hutR or hutA mutation in the tonB
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mutant background.  Because the contribution of HasR to hemin utilization was
relatively minor compared to HutA and HutR (Table 3, page 79, and Table 6), it
was not necessary to eliminate hasR expression from these strains.  A tonB, hutR
mutant ARM213 used hemin efficiently when provided with either the tonB1 or
the tonB2 system genes on a plasmid (Table 6), suggesting that HutA does not
have an absolute specificity for TonB1.  Hemin utilization was similarly restored
to the tonB, hutA mutant ARM215 when either set of tonB genes was supplied on
a plasmid, suggesting that HutR also functions with both TonB systems (Table 6).
In both cases, strains carrying the TonB1 system genes had larger zones of growth
around hemin than strains carrying the TonB2 system genes.  Although
overexpression of the heme transporters HutBCD encoded by the tonB1 plasmid
may have contributed to the growth observed, this does not fully account for the
growth advantage of strains expressing the tonB1 genes.  A plasmid carrying only
tonB1exbB1exbD1 (pAMT12) conferred hemin utilization in the parental strain
DHH11 as efficiently as a tonB1exbB1exbD1 plasmid carrying additionally
hutBCD (pAMT112) (Table 6).  Taken together, these data indicate that TonB1
may facilitate heme transport through either HutA or HutR more efficiently than
TonB2.
To study the TonB-dependence of heme transport through HasR, a hutA,
hutR mutant was created in the tonB-deficient strain DHH11.  This mutant,
ARM219, exhibited a small amount of growth around hemin in a bioassay when
supplied with the tonB2 genes, but not when supplied with the tonB1 genes
(Table 6). Heme uptake through HasR must therefore specifically require TonB2.
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Table 6.  TonB-dependence of HutA, HutR, and HasR.







DHH11/pWKS30 HutA, HutR, HasR None 25 NG NG NG
DHH11/pAMT112 HutA, HutR, HasR TonB1 24 15 28 NG
DHH11/pAMT12 HutA, HutR, HasR TonB1 25 15 27 NG
DHH11/pOUT11 HutA, HutR, HasR TonB2 24 11 28 30
ARM213/pAMT112 HutA, HasR TonB1 24 15 29 NG
ARM213/pOUT11 HutA, HasR TonB2 25 11 28 30
ARM215/pAMT112 HutR, HasR TonB1 23 11 27 NG
ARM215/pOUT11 HutR, HasR TonB2 23 8 28 30
ARM219/pAMT112 HasR TonB1 23 NG 27 NG
ARM219/pOUT11/pACYC184 HasR TonB2 24 6 (faint) 26 28
ARM219/pOUT11/pAMH20 HutA, HasR TonB2 23 12 26 27
ARM219/pOUT11/pAMR14 HutR, HasR TonB2 23 12 27 29
a.  The indicated strains were seeded at 106 cells per ml into molten L agar containing 100 µg EDDA per ml.  Iron sources were spotted
onto the solidified agar as follows:  20 µl 10 mM FeSO4; 5 µl CA401 overnight culture (vibriobactin); 5 µl  DH5α overnight culture
(enterobactin); 5 µl 50 µM hemin.  NG=No growth.  Plates were incubated for 24 hrs at 37°C, then for 24 hrs at room temperature, and
the diameter of each zone of growth was measured.  The assays were repeated at least 3 times.  Although the relative differences
between strains were consistent between experiments, the absolute values for each strain varied due to subtle changes in the media and
assay conditions, and thus only one representative experiment is shown.
b.  All strains are derived from CA40130, and thus are Vib-.
c.  Vibriobactin utilization shows proper TonB function.
d.  Enterobactin utilization specifically demonstrates TonB2 function.
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TonB2 facilitated hemin utilization more efficiently when either HutA or HutR
was present than when only HasR was present (Table 6).  These data support the
above conclusion that TonB2 is able to promote heme transport through both
HutA and HutR.  However, to establish conclusively that TonB2 interacts
productively with HutA and HutR, the tonB, hutA, hutR mutant ARM219 was
supplied with the tonB2 system genes and tested for hemin utilization in the
presence or absence of a hutA or hutR clone.  Plasmid-encoded HutA or HutR
significantly increased the level of TonB2-dependent hemin utilization in these
strains (Table 6).  These data confirm that both receptors can use TonB2;
nevertheless, HutA and HutR may both require TonB1 for optimal heme
transport.
9.  ROLE OF HEME UPTAKE FOR GROWTH OF V. CHOLERAE IN VIVO
The infant mouse model of V. cholerae infection (166) was used to
investigate the role of heme uptake for growth of V. cholerae in the mammalian
host.  Five-day old BALB/c mice were inoculated intragastrically with equal
numbers of the triple heme receptor mutant ARM932 and its Vib- parental strain
CA40130N.  The ability of the heme receptor mutant to compete with the parental
strain in vivo was determined by counting the numbers of viable ARM932 and
CA40130N cells recovered from the intestines after 24 hours.  The mean
competitive index of ARM932 to CA40130N did not deviate significantly from
1.0 (mean = 0.94; range = 0.8-1.2; data collected from seven mice), indicating
that the heme uptake mutant did not have an in vivo growth defect compared to its
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Vib- parental strain.  These data suggest that iron sources in addition to heme are
available to V. cholerae colonizing the infant mouse.
10.  SOURCES OF HEME IN THE MARINE ENVIRONMENT
The presence of three functional heme receptors in V. cholerae suggests
that heme is an important nutrient for this organism.  V. cholerae has been
isolated from a variety of marine organisms, including crustaceans and molluskan
shellfish (137), and it is possible that hemolymph from these animals can provide
V. cholerae with heme-iron.  To determine if heme sources from potential marine
hosts can be used efficiently by V. cholerae, iron-starved V. cholerae was tested
for ability to use hemoglobin preparations from two marine invertebrates,
Barbatia reeveana (117) and Urechis caupo (56), as sources of iron.  The parental
strain CA40130N used both sources of heme, whereas the triple heme receptor
mutant ARM932 was unable to grow using either type of hemoglobin as an iron
source (Table 7).  These data indicate that V. cholerae can readily assimilate heme
derived from these invertebrates, and thus may be able to take advantage of the
abundant sources of heme present in the marine environment.
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Table 7.  Utilization of marine invertebrate hemoglobin by V. cholerae.
Growth after 48 hoursa




CA40130N parent + + +
ARM932 HutA-, HutR-, HasR- + – –
a.  The indicated strains were seeded at 106 cells per ml into molten L agar containing 100 µg EDDA per ml.  Iron sources
were spotted onto the solidified agar as follows:  20 µl 10 mM FeSO4; 5 µl marine invertebrate hemoglobin preparation
(50 µM heme content).  Plates were incubated for 24 hrs at 37°C, then for 24 hrs at room temperature.  + indicates a zone
of growth > 15 mm; – indicates no growth around the iron source.
b.  All strains are derived from CA40130N and thus are Vib-.
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B.  Characterization of domains involved in the interaction between
TonB and TonB-dependent receptors
Data presented in this dissertation and in Seliger et al., 2001, indicate that
V. cholerae TonB1 may be specific for a subset of V. cholerae outer membrane
receptors.  The specificity of TonB1 for particular receptors has been
demonstrated also by studies in E. coli.  The V. cholerae tonB1, exbB1, exbD1
genes do not complement an E. coli tonB mutation, suggesting that V. cholerae
tonB1 does not recognize E. coli TonB-dependent receptors.  Further, the ability
of the V. cholerae heme receptor HutA to mediate efficient heme utilization in E.
coli requires the V. cholerae tonB1 system genes (68, 124).  Thus, the E. coli
TonB and V. cholerae TonB1 systems are not functionally interchangeable, and
the hypothesis can be made that the V. cholerae TonB1 protein does not recognize
or functionally interact with E. coli outer membrane receptors, and vice versa.
The specificity exhibited by E. coli and V. cholerae TonB proteins for outer
membrane receptors of their own species is consistent with a direct interaction
between TonB and the receptors.  To investigate the basis for the receptor
specificity exhibited by TonB1, and to define the region(s) of the TonB proteins
involved in the TonB-receptor interaction, a series of TonB chimeras was
constructed between E. coli TonB and V. cholerae TonB1.
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1.  CONSTRUCTION OF HYBRID TONB GENES
The hybrid tonB genes were created by exchanging equivalent E. coli tonB
and V. cholerae tonB1 fragments using unique restriction sites engineered into the
genes by PCR (Fig. 5, page 57).  These restriction sites did not alter the efficacy
or the specificity of the TonB proteins when compared with the corresponding
wild type TonB in functional assays (data not shown).  The V. cholerae TonB1 N-
terminus does not recognize the native E. coli ExbB and ExbD proteins (124), and
thus it was necessary to include the V. cholerae exbBD1 genes in all constructs
encoding the N-terminal domain of V. cholerae TonB1.  In addition, heme uptake
via the HutA/TonB1 pair in E. coli was more efficient when the heme transport
genes hutBCD were expressed as well (data not shown).  Therefore, to maintain
consistency, all native and chimeric tonB genes were inserted in place of V.
cholerae tonB1 in the context of the entire V. cholerae tonB1, exbBD1, hutBCD
operon (Fig. 11).  To ensure translation of V. cholerae genes cloned behind E. coli
tonB, a Shine-Dalgarno consensus sequence was introduced by PCR immediately
upstream of exbB1.  Expression of the V. cholerae genes cloned in this manner
was tested by complementation of V. cholerae exbB or exbD mutations (data not
shown).  The level of expression of the hybrid TonBs was not determined.  It is
possible that the growth phenotype associated with a hybrid TonB could be due to
overexpression or poor expression of the hybrid TonB protein rather than to
receptor specificity.  For example, the absence of growth could be due to poor
expression of a TonB hybrid, whereas enhanced growth could be attributable to
overexpression of a poorly functioning hybrid.  This issue remains to be resolved.
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Figure 11.  E. coli and V. cholerae tonB gene fusions.
The restriction sites shown were engineered in by PCR, and the fusions were
created by cutting and ligating the relevant fragments.  The hutBCD genes encode
V. cholerae heme-specific transport proteins that were found to increase the
efficiency of heme utilization in the E. coli strain carrying these constructs.  Blue




2 .  F UNCTIONAL ANALYSIS OF E. COLI AND V. CHOLERAE TO NB CHIMERAS
INVOLVING THE C-TERMINAL DOMAIN OF TONB
TonB is composed of three functional domains:  the N-terminal domain,
involved in the association with the inner membrane; the central proline rich
domain, which plays a role in spanning the periplasm; and the C-terminal domain,
which mediates interactions with the outer membrane.  To study the role of the C-
terminal domain in receptor recognition, chimeras were created that switched this
domain between E. coli TonB and V. cholerae TonB1.  The chimeras were
constructed by introducing an XbaI site into each tonB gene in region encoding
the central proline-rich domain in each TonB.  Whereas the XbaI mutation in the
E. coli tonB gene was silent, the mutation in V. cholerae TonB1 resulted in the
insertion of a Ser residue, thus making V. cholerae TonB1 more similar to E. coli
TonB.  The mutations did not alter the efficacy or specificity of the TonB
proteins, as determined by comparisons with the corresponding wild type TonB in
functional assays (data not shown).  To determine the specificity of the native and
hybrid TonBs in E. coli, tonB constructs were expressed in the E. coli tonB, entF
mutant ARM100.  This enterobactin synthesis mutant was used in order to reduce
background growth in halo assays due to enterobactin-mediated utilization of iron
sources in the media.  This was particularly important for distinguishing between
growth due to utilization of heme as an iron source, and growth due to
enterobactin-mediated scavenging of free iron in the hemin preparations.  The
tonB constructs were tested for ability to confer heme utilization through
V. cholerae HutA, and utilization of enterobactin or ferrichrome via the E. coli
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receptors FepA or FhuA, respectively (Table 8 and Table 9).  Heme utilization
was only observed in strains expressing V. cholerae hutA (Table 8 and Table 9),
and expression of hutA from a plasmid did not interfere with enterobactin or
ferrichrome utilization (Table 9).  Native E. coli TonB (construct pAMT111)
permitted uptake of enterobactin and ferrichrome through the E. coli receptors
FepA and FhuA, respectively, but did not mediate efficient heme uptake through
the V. cholerae receptor HutA, suggesting that E. coli TonB interacts poorly with
HutA (Table 9 and Fig. 12).  In contrast, V. cholerae TonB1 (construct
pAMT112) was unable to facilitate transport through any of the E. coli receptors
tested, but was able to promote heme uptake via HutA, demonstrating that V.
cholerae TonB1 has an absolute specificity for V. cholerae receptors (Table 9 and
Fig. 13).  Thus, both E. coli TonB and V. cholerae TonB1 exhibit a degree of
specificity for receptors of their own species.  Replacing the carboxy-terminal 121
amino acids of E. coli TonB with the equivalent region from V. cholerae TonB1
produced a functional TonB (construct pAMT113) that allowed transport through
V. cholerae HutA, but not through the E. coli  receptors (Table 9 and Fig. 14).
This E. coli TonB/V. cholerae TonB1 (e/v1) hybrid is therefore functionally
equivalent to V. cholerae TonB1.  Conversely, replacing the carboxy-terminal 125
residues of V. cholerae TonB1 with the equivalent region from E. coli TonB
produced a functional TonB (construct pAMT114) that permitted transport
through E. coli FepA and FhuA, but did not mediate efficient heme uptake
through V. cholerae HutA.  Thus, this V. cholerae TonB1/E. coli TonB (v1/e)
hybrid is functionally equivalent to wild type E. coli TonB (Table 9 and Fig 15).
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Table 8.  Role of the Carboxy-terminal domain of TonB in TonB-receptor interaction specificity.





 FeSO4 Ferrichrome Enterobactin Hemin
pWKS30∆X TonB- 20 NG NG NG
pAMT111 e TonBX 22 16 25 NG
pAMT112 v1 TonBX 20 NG NG NG
pAMT113 e1-119/v1122-245TonBX 20 NG NG NG
pAMT114 v11-121/e120-239TonBX 22 16 26 NG
a.  The indicated strains were seeded at 106 cells per ml into molten L agar containing 100 µg EDDA per ml.  Iron sources were
spotted onto the solidified agar as follows:  20 µl 10 mM FeSO4; 5 µl 40 µM Ferrichrome; 5 µl DH5α overnight culture
(enterobactin); 5 µl 50 µM hemin.  NG = No growth.  Plates were incubated for 24 hrs at 37°C, and the diameter of each zone
of growth was measured.  The assays were repeated at least 3 times.  Although the relative differences between strains were
consistent between experiments, the absolute values for each strain varied due to subtle changes in the media and assay
conditions, and thus only one representative experiment is shown.
b.  E. coli TonBX is denoted by e TonBX; V. cholerae TonB1X is denoted by v1 TonBX.
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Table 9.  Role of the C-terminal domain of TonB in specificity for E. coli and V. cholerae receptors.
Zone of growth (mm) after 24 hoursa
ARM100 (TonB-, EntF-)/
pAMH20c  transformed with:
Relevant TonB
characteristicsb
FeSO4 Ferrichrome Enterobactin Hemin
pWKS30∆X TonB- 20 NG NG NG
pAMT111 e TonBX 20 13 22 10 (faint)
pAMT112 v1 TonBX 19 NG NG 12
pAMT113 e1-119/v1122-245TonBX 18 NG NG 12
pAMT114 v11-121/e120-239TonBX 22 14 23 10 (faint)
a.  The indicated strains were seeded at 106 cells per ml into molten L agar containing 100 µg EDDA per ml.  Iron sources were
spotted onto the solidified agar as follows:  20 µl 10 mM FeSO4; 5 µl 40 µM Ferrichrome; 5 µl DH5α overnight culture
(enterobactin); 5 µl 50 µM hemin.  NG = No growth.  Plates were incubated for 24 hrs at 37°C, and the diameter of each zone
of growth was measured.  The assays were repeated at least 3 times.  Although the relative differences between strains were
consistent between experiments, the absolute values for each strain varied due to subtle changes in the media and assay
conditions, and thus only one representative experiment is shown.
b.  E. coli TonBX is denoted by e TonBX; V. cholerae TonB1X is denoted by v1 TonBX.
c.  Encodes the V. cholerae outer membrane receptor for heme, HutA.
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Figure 12.  E. coli TonB-dependent transport of iron substrates in E. coli
ARM100.
The E. coli TonB, ExbB, ExbD complex facilitates transport of ferrichrome
through the E. coli receptor FhuA, but does not promote efficient heme uptake via
the V. cholerae receptor HutA in this E. coli strain.
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Figure 13.  V. cholerae TonB1-dependent transport of iron complexes in E. coli.
The V. cholerae TonB1, ExbB1, ExbD1 complex permits heme uptake via the
V. cholerae receptor HutA, but does not facilitate ferrichrome transport through
the E. coli receptor FhuA in this E. coli strain.
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Figure 14.  Transport of iron complexes via a chimeric e/v1 TonB protein in E.
coli.
A chimeric TonB protein, composed of the N-terminal domain of E. coli TonB
fused to the C-terminal domain of V. cholerae TonB1, permits heme transport
through V. cholerae HutA, but not ferrichrome transport through E. coli FhuA.




Figure 15.  Transport of iron complexes via a chimeric v1/e TonB protein in E.
coli.
A chimeric TonB protein, composed of the N-terminal domain of V. cholerae
TonB1 fused to the C-terminal domain of E. coli TonB, permits ferrichrome
transport through E. coli FhuA, but only weak heme uptake through V. cholerae
HutA.  Thus, this chimera is functionally equivalent to E. coli TonB.
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These data suggest that a region within the carboxy-terminal half of TonB is
involved in determining the specificity of the interaction with outer membrane
receptors.
To characterize further the TonB-receptor interaction, TonB hybrids
involving smaller portions of the C-termini were tested to define a minimal region
required to switch the TonB receptor-specificity from one species to another.  A
set of TonB chimeras was created in which the C-terminal 66 amino acids from
each TonB protein were switched.  This domain swap did not include the
conserved Gln160 residue previously implicated in the direct interaction between
E. coli TonB and the TonB box of the BtuB receptor in E. coli (7, 25).  The hybrid
genes were constructed by introducing a XhoI site into each tonB gene and
exchanging equivalent fragments.  The XhoI mutation resulted in an Ile to Leu
change in both TonB proteins; however, this change did not adversely affect the
function of either TonB in functional assays (Table 10).  The native and hybrid
tonB constructs were tested as described above.  pAMT124, encoding the v1/e
TonB chimera, conferred the ability to use enterobactin and ferrichrome, but did
not allow efficient heme utilization.  Thus, this chimera exhibited the specificities
associated with E. coli TonB, indicating that the C-terminal 66 amino acids of E.
coli TonB are sufficient for recognizing E. coli receptors.  The reciprocal e/v1
chimera, encoded by pAMT123, did not have any TonB activity, suggesting that
an important functional domain was disrupted in this hybrid.
A set of chimeras was created in which the C-terminal 31 amino acids
were switched between E. coli TonB and V. cholerae TonB1.  These hybrids were
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Table 10.  Analysis of chimeras involving the C-terminal 66 residues of E. coli TonB and V. cholerae TonB1.
Zone of growth (mm) after 24 hoursa
ARM100 (TonB-, EntF-)/




pWKS30∆X TonB- 15 NG NG
pAMT121 e TonBXXh 19 20 10 (faint)
pAMT122 v1 TonBXXh 16 NG 13
pAMT123 e1-172/v1179-245TonBXXh 17 NG NG
pAMT124 v11-178/e173-239TonBXXh 17 21 11 (faint)
a.  The indicated strains were seeded at 106 cells per ml into molten L agar containing 100 µg EDDA per ml.  Iron sources were
spotted onto the solidified agar as follows:  20 µl 10 mM FeSO4; 5 µl DH5α overnight culture (enterobactin); 5 µl 50 µM
hemin.  NG = No growth.  Plates were incubated for 24 hrs at 37°C, and the diameter of each zone of growth was measured.
The assays were repeated at least 3 times.  Although the relative differences between strains were consistent between
experiments, the absolute values for each strain varied due to subtle changes in the media and assay conditions, and thus
only one representative experiment is shown.
b.  E. coli TonBXXh is denoted by e TonBXXh; V. cholerae TonB1XXh is denoted by v1 TonBXXh.
c.  Encodes the V. cholerae outer membrane receptor for heme, HutA.
122
constructed by engineering unique MluI sites into the tonB genes and switching
the relevant fragments.  The MluI mutation resulted in Glu to Asp and Ile to Leu
changes in V. cholerae TonB1, and a Met to Leu change in E. coli TonB.  These
amino acid changes did not influence the activities of the TonB proteins in
functional assays; however, neither of the chimeric TonBs exhibited any TonB
activity, indicating that this switch disrupts important structural or functional
motifs (Table 11).  All other attempts at switching fewer than 66 residues resulted
in non-functional chimeras, suggesting that this C-terminal region constitutes an
important functional domain of TonB that relies on many specific intramolecular
interactions to form properly.
3.  IDENTIFICATION OF A MINIMAL REGION OF V. CHOLERAE TONB1
REQUIRED TO CONFER SPECIFICITY FOR V. CHOLERAE RECEPTORS
To identify the minimal region of V. cholerae TonB1 necessary to confer
the specificities associated with the TonB1 protein, hybrids were created between
E. coli TonB and V. cholerae TonB1 that included progressively fewer than 120
TonB1 C-terminal residues.  The tonB genes encoding these hybrids were
engineered without the insertion of restriction sites, and thus no changes in the
amino acid sequences of the TonB proteins were incurred.  The chimera encoded
by pAMT173, containing the N-terminal 158 residues of E. coli TonB joined to
the C-terminal 88 residues of V. cholerae TonB1, allowed heme utilization via
V. cholerae HutA, but did not permit enterobactin utilization via E. coli FepA, or
ferrichrome utilization via E. coli FhuA, indicating that this chimera is specific for
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Table 11.  Analysis of chimeras involving the C-terminal 31 residues of E. coli TonB and V. cholerae TonB1.






pWKS30∆X TonB- 15 NG NG
pAMT131 e TonBXM 17 20 11 (faint)
pAMT132 v1 TonBXM 16 NG NG
pAMT133 e1-208/v1215-245TonBXM 16 NG NG
pAMT134 v11-214/e209-239TonBXM 17 NG NG
a.  The indicated strains were seeded at 106 cells per ml into molten L agar containing 100 µg EDDA per ml.  Iron sources
were spotted onto the solidified agar as follows:  20 µl 10 mM FeSO4; 5 µl DH5α overnight culture (enterobactin); 5 µl
50 µM hemin.  NG = No growth.  Plates were incubated for 24 hrs at 37°C, and the diameter of each zone of growth was
measured.  The assays were repeated at least 3 times.  Although the relative differences between strains were consistent
between experiments, the absolute values for each strain varied due to subtle changes in the media and assay conditions,
and thus only one representative experiment is shown.
b.  E. coli TonBXM is denoted by e TonBXM; V. cholerae TonB1XM is denoted by v1 TonBXM.
c.  Encodes the V. cholerae outer membrane receptor for heme, HutA.
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V. cholerae receptors (Table 12).  This chimera therefore contains the region of V.
cholerae TonB1 involved in determining specificity.
The portion of TonB1 encoded by pAMT173 includes a short stretch of
amino acids that does not align well with E. coli TonB, or with V. cholerae
TonB2 (Fig. 16).  To determine if specificity determinants are contained within
this region of TonB1, an e/v1 chimera lacking these residues was constructed by
joining the C-terminal 81 amino acids of TonB1 to the N-terminal 158 amino
acids of E. coli TonB.  This chimera, encoded by pAMT183, exhibited all the
expected TonB1 specificities, and had wild type levels of TonB1 activity (Table
12), indicating that the missing residues were not required for TonB1 activity or
specificity.  These data demonstrate that the C-terminal 81 amino acids of TonB1
are sufficient to confer the specificities exhibited by V. cholerae TonB1.  Because
the chimera encoded by pAMT183 is shorter than the chimera encoded by
pAMT173, the data also imply that, in E. coli, the activities of the TonB chimeras
are not sensitive to small variations in length.
4.  ISOLATION OF A V. CHOLERAE TONB1 POINT MUTANT CAPABLE OF
INTERACTING WITH E. COLI RECEPTORS
To pinpoint specific residues important for determining the narrow
receptor specificity of V. cholerae TonB1, E. coli ARM100 (EntF-; TonB-)
carrying a plasmid encoding the V. cholerae TonB1 complex was grown in iron-
limiting media containing only enterobactin or ferrichrome as iron sources.  As
expected, no growth was visible around either iron source after 24 hours, since
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Table 12.  Identification of a minimal V. cholerae TonB1 C-terminal domain required for specificity.
Zone of growth (mm) after 48 hoursa
ARM100 (TonB-, EntF-)/




pWKS30∆X TonB- 15 NG NG
pAMT111 e TonBX 20 28 10 (faint)
pAMT112 v1 TonBX 16 NG 13
pAMT173 e1-158/v1158-245TonBX 19 NG 12
pAMT183 e1-158/v1165-245TonBX 17 NG 12
a.  The indicated strains were seeded at 106 cells per ml into molten L agar containing 100 µg EDDA per ml.  Iron sources
were spotted onto the solidified agar as follows:  20 µl 10 mM FeSO4; 5 µl DH5α overnight culture (enterobactin); 5 µl
50 µM hemin.  NG = No growth.  Plates were incubated for 24 hrs at 37°C, then for 24 hrs at room temperature, and the
diameter of each zone of growth was measured.  The assays were repeated at least 3 times.  Although the relative
differences between strains were consistent between experiments, the absolute values for each strain varied due to subtle
changes in the assay conditions, and thus only one representative experiment is shown.
b.  E. coli TonBX is denoted by e TonBX; V. cholerae TonB1X is denoted by v1 TonBX.
c.  Encodes the V. cholerae outer membrane receptor for heme, HutA.
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Figure 16.  Alignment of V. cholerae TonB1, V. cholerae TonB2 and E. coli
TonB.
The amino acid sequences of V. cholerae TonB1, V. cholerae TonB2 and E. coli
TonB were aligned using CLUSTAL-W.  The region of TonB1 included in the
chimera encoded by pAMT173, but not in the chimera encoded by pAMT183, is
boxed in red.  The site of the Pro237Thr gain-of-function mutation in V. cholerae
TonB1 is highlighted in yellow.
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V. cholerae TonB1 does not recognize either the enterobactin receptor FepA or
the ferrichrome receptor FhuA in E. coli.  However, after further incubation at
room temperature for up to one week, a small number of colonies became visible
in the agar surrounding the iron sources, possibly as a result of mutations
facilitating the productive interaction between V. cholerae TonB1 and E. coli
FepA or FhuA.  To analyze potential mutants, single colonies were tested again in
halo assays to verify the transport phenotype.  A mutant was obtained which
exhibited growth around both enterobactin and ferrichrome, suggesting that this
strain expressed a V. cholerae TonB1 variant capable of interacting with multiple
E. coli receptors.  To verify that a mutation(s) had occurred in V. cholerae tonB1,
the tonB1 plasmid was retransformed into a fresh background.  The newly
transformed strain was able to use both enterobactin and ferrichrome (Table 13).
Sequencing of the tonB1 gene on the plasmid now designated pAMT112.m1
showed that it carried a mutation resulting in a Pro to Thr substitution at residue
238 TonB1X.  This residue corresponds to position 237 in the wild type TonB1
protein, and therefore the designation 237* will be used to describe this position
in TonB1X.  Pro237 is very close to the C-terminus of TonB1 (Fig. 16).  This
suggests that either there is a receptor interaction site at the very C-terminus of
TonB1, or mutations in this region influence an interaction domain(s) elsewhere
in TonB1.
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Table 13.  Specificity of a V. cholerae TonB1 Pro237Thr mutant.





 FeSO4 Ferrichrome Enterobactin
pWKS30∆X TonB- 20 NG NG
pAMT111 eTonBX 22 16 26
pAMT112 vTonB1X 20 NG NG
pAMT112.m1 vTonB1X P237*T 20 13 22
a.  The indicated strains were seeded at 106 cells per ml into molten L agar containing 100 µg EDDA per ml.  Iron sources
were spotted onto the solidified agar as follows:  20 µl 10 mM FeSO4; 5 µl 40 µM Ferrichrome; 5 µl DH5α overnight
culture (enterobactin.  NG = No growth.  Plates were incubated for 24 hrs at 37°C, and the diameter of each zone of
growth was measured.  The assays were repeated at least 3 times.  Although the relative differences between strains were
consistent between experiments, the absolute values for each strain varied due to subtle changes in the media and assay
conditions, and thus only one representative experiment is shown.
b.  e denotes  E. coli; v denotes V. cholerae.
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5.  FUNCTIONAL ANALYSIS OF V. CHOLERAE AND E. COLI HEME RECEPTOR
CHIMERAS INVOLVING THE N-TERMINAL TONB BOX DOMAIN
The TonB box region of TonB-dependent receptors has been proposed to
be important for the productive interaction with TonB.  A comparison of the
known V. cholerae and E. coli TonB boxes reveals that the V. cholerae HutA
TonB box differs significantly from the E. coli TonB boxes, particularly at
positions that are highly conserved among the E. coli TonB boxes (Fig. 17).
Thus, the specificity exhibited by V. cholerae TonB1 and E. coli TonB for certain
receptors may in part be due to a requirement for a particular TonB box sequence.
To investigate this hypothesis, chimeras were constructed between E. coli and
V. cholerae receptors in which the TonB box heptapeptides were switched.  The
chimeras were then tested for ability to function with either V. cholerae TonB1 or
E. coli TonB in iron utilization assays in E. coli ARM100.  
To test whether the presence of the HutA TonB box is sufficient to allow
TonB1 to recognize an E. coli receptor, the TonB box of the E. coli heme receptor
ChuA was replaced with the HutA TonB box.  The resulting ChuA (HutA TonB
box) chimera was tested for dependence on either V. cholerae TonB1 or E. coli
TonB.  Table 14 shows that ChuA (HutA TonB box) facilitated heme uptake
using E. coli TonB, but not V. cholerae TonB1, indicating that the TonB-
dependence of this chimera is identical to that of the wild type ChuA protein.  The
level of heme utilization via the chimeric receptor was similar to that observed for
wild type ChuA; thus, binding and transport of heme was not compromised by the
TonB box substitution (Table 14).  Taken together, these data suggest that
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Figure 17.  Predicted E. coli and V. cholerae receptor TonB boxes
The proposed TonB box (underlined) and the residue immediately preceding the
TonB box heptapeptide are shown for several E. coli and V. cholerae receptors.
E. coli sequences are shown in blue and V. cholerae sequences are shown in red.
The V. cholerae vibriobactin receptor ViuA does not contain an N-terminal
sequence with homology to any of the predicted E. coli or V. cholerae TonB
boxes, as is indicated by a question mark.  The TonB-dependencies of each




Table 14.  TonB-dependence of ChuA and ChuAHutA TonB box in E. coli.
Zone of growth (mm) after 48 hoursa
ARM100 (TonB-, EntF-)
transformed with:
Relevant Phenotypeb FeSO4 Enterobactin Hemin
pWKS30∆X/pChuA TonB-, ChuA+ 21 NG NG
pAMT111/pChuA eTonBX+, ChuA+ 20 28 16
pAMT112/pChuA vTonB1X+, ChuA+ 21 NG NG
pAMT111/pAMC22 eTonBX+, ChuAHutA TonB box
+ 20 25 15
pAMT112/pAMC22 vTonB1X+, ChuAHutA TonB box
+ 21 NG NG
a.  The indicated strains were seeded at 106 cells per ml into molten L agar containing 100 µg EDDA per ml.  Iron sources
were spotted onto the solidified agar as follows:  20 µl 10 mM FeSO4; 5 µl DH5α overnight culture (enterobactin); 5 µl
50 µM hemin.  NG = No growth.  Plates were incubated for 24 hrs at 37°C, then for 24 hrs at room temperature, and the
diameter of each zone of growth was measured.  The assays were repeated at least 3 times.  Although the relative
differences between strains were consistent between experiments, the absolute values for each strain varied due to subtle
changes in the media and assay conditions, and thus only one representative experiment is shown.
b.  e denotes  E. coli; v denotes V. cholerae.
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residues apart from, or in addition to, the TonB box heptapeptide are required for
the productive interaction with V. cholerae TonB1.  Because the TonB box
substitution did not influence the ability of E. coli TonB to recognize ChuA, the
data also imply that the ChuA TonB box is not specifically required for the
interaction with E. coli TonB.
A reciprocal chimera was constructed in which the TonB box of
V. cholerae HutA was replaced with the TonB box from E. coli ChuA.  The HutA
(ChuA TonB box) chimera was tested for ability to mediate heme utilization using
either V. cholerae TonB1 or E. coli TonB in a broth culture growth assay.  This
assay method was chosen in order to quantify more accurately the observed
growth differences attributable to this particular TonB box substitution.  The data
show that E. coli TonB mediated heme utilization more efficiently through the
HutA (ChuA TonB box) chimera than through the wild type HutA receptor,
suggesting that the presence of the ChuA TonB box promoted a stronger
interaction with E. coli TonB (Fig. 18).  It is not clear from these data whether
E. coli TonB specifically recognizes the ChuA TonB box in the context of HutA,
or whether the TonB box substitution affects a TonB interaction site elsewhere in
the HutA receptor.  The level of V. cholerae TonB1-mediated heme utilization via
the HutA (ChuA TonB box) chimera was essentially unchanged compared with
the level achieved via wild type HutA, indicating that the TonB box substitution
did not adversely affect either the heme transport functions of HutA or the ability
of HutA to interact with V. cholerae TonB1 (Fig. 18).  These data support the
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Figure 18.  Heme uptake via HutA carrying the ChuA TonB box.
Strains were inoculated into L broth containing 75 µg EDDA per ml, and 5 µM
hemin.  The optical density was measured after 24 hrs.  Growth in iron-replete
media was comparable for all the strains tested, and none of the strains grew in
iron-depleted media (data not shown).  Each data point represents the mean
optical density from three independently grown cultures.  Standard deviations are





































above conclusion that residues elsewhere in the HutA receptor contribute to the
specificity of the interaction with V. cholerae TonB1.
To test whether a TonB box from an E. coli receptor with a different
substrate than heme would have a similar effect on HutA as the ChuA TonB box,
the E. coli enterobactin receptor FepA TonB box was introduced into HutA.  This
chimera did not function with either E. coli TonB or V. cholerae TonB1 in an iron
utilization assay in E.coli, implying that the FepA TonB box is incompatible with
HutA (Table 15).  This result was somewhat surprising, given that the HutA TonB
box is more similar to the FepA TonB box than to the ChuA TonB box (Fig. 17,
page 134).
In conclusion, the specificity of the TonB-receptor interaction does not
appear to be dictated by specific residues within the TonB box heptapeptide.  The
presence of a heterologous TonB box within a receptor did not diminish
productive interactions with the native TonB protein, implying that other
regions(s) of the receptor contain the specificity determinants.  However, a
heterologous TonB box may influence the productive interaction with TonB by
increasing the efficiency of a weak interaction, such as that between V. cholerae
HutA and E. coli TonB, or by eliminating the receptor transport function
altogether, as evidenced by the non-functional HutA (FepA TonB box) chimera.
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Table 15.  TonB-dependence of HutA and HutAFepA TonB box in E. coli.
Zone of growth (mm) after 48 hoursa
ARM100 (TonB-, EntF-)
transformed with:
Relevant Phenotypeb FeSO4 Enterobactin Hemin
pWKS30∆X/pAMH20 TonB-, HutA+ 20 NG NG
pAMT111/pAMH20 eTonBX+, HutA+ 20 26 10 (faint)
pAMT112/pAMH20 vTonB1X+, HutA+ 19 NG 12
pAMT111/pAMH21 eTonBX+, HutAFepA TonB box
+ 20 27 NG
pAMT112/pAMH21 vTonB1X+, HutAFepA TonB box
+ 20 NG NG
a.  The indicated strains were seeded at 106 cells per ml into molten L agar containing 100 µg EDDA per ml.  Iron sources
were spotted onto the solidified agar as follows:  20 µl 10 mM FeSO4; 5 µl DH5α overnight culture (enterobactin); 5 µl
50 µM hemin.  NG = No growth.  Plates were incubated for 24 hrs at 37°C, then for 24 hrs at room temperature, and the
diameter of each zone of growth was measured.  The assays were repeated at least 3 times.  Although the relative
differences between strains were consistent between experiments, the absolute values for each strain varied due to subtle
changes in the media and assay conditions, and thus only one representative experiment is shown.
b.  e denotes  E. coli; v denotes V. cholerae.
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6.  ISOLATION OF AN E. COLI FEPA MUTANT CAPABLE OF INTERACTING WITH
V. CHOLERAE TONB1
To identify specific receptor residues involved in recognizing V. cholerae
TonB1, E. coli ARM100 carrying a plasmid encoding the V. cholerae TonB1
complex was grown in a halo assay using enterobactin as the sole source of iron.
A small number of colonies used enterobactin, possibly as a result of gain-of-
function mutations allowing productive interactions between V. cholerae TonB1
and the chromosomally encoded E. coli FepA.  A candidate mutant strain was
analyzed by curing the strain of the TonB1 plasmid and retransforming the strain
with a plasmid encoding either V. cholerae TonB1 or E. coli TonB.  The freshly
transformed mutant strain used enterobactin in the presence of either of the two
TonBs, indicating that the mutation did not affect the ability of FepA to recognize
E. coli TonB (Table 16).  Sequencing of the candidate gain-of-function fepA allele
showed that it contained a mutation resulting in an Asp11Tyr substitution in the
mature FepA protein.  To verify that the Asp11Tyr mutation was responsible for
the productive interaction of FepA with V. cholerae TonB1, the mutation was re-
constructed within a wild type fepA gene on a plasmid.  The fepAD11Y plasmid
conferred enterobactin utilization in ARM100 carrying the tonB1 system plasmid,
whereas the wild type fepA plasmid did not (Table 16).  These data confirm the
gain-of function phenotype of the FepAD11Y mutation.  Interestingly, the
substituted residue in FepAD11Y immediately precedes the TonB box in the FepA
amino acid sequence, strongly implicating this N-terminal receptor region in the
interaction with TonB.
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Table 16.  TonB-dependence of FepA and FepAD11Y in E. coli.
Zone of growth (mm) after 24 hoursa
Strain Relevant Phenotypeb FeSO4 Enterobactin Ferrichrome
ARM100/pWKS30∆X TonB-, FepA+ 20 NG NG
ARM100/pAMT111 eTonBX+, FepA+ 22 25 15
ARM100/pAMT112 vTonB1X+, FepA+ 20 NG NG
ARM107/pAMT111 eTonBX+, FepAD11Y
+ 20 25 15
ARM107/pAMT112 vTonB1X+, FepAD11Y
+ 21 22 NG
ARM100/pAMT112/pFepA vTonB1X+, FepA+ 23 NG NG
ARM100/pAMT112/pFepAD11Y vTonB1X
+ , FepAD11Y
+ 22 23 NG
a.  The indicated strains were seeded at 106 cells per ml into molten L agar containing 100 µg EDDA per ml.  Iron sources were spotted onto
the solidified agar as follows:  20 µl 10 mM FeSO4; 5 µl DH5α overnight culture (enterobactin); 5 µl 50 µM hemin.  NG = No growth.
Plates were incubated for 24 hrs at 37°C, and the diameter of each zone of growth was measured.  The assays were repeated at least 3
times.  Although the relative differences between strains were consistent between experiments, the absolute values for each strain varied
due to subtle changes in the media and assay conditions, and thus only one representative experiment is shown.
b.  e denotes  E. coli; v denotes V. cholerae.
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7.  ANALYSIS OF AN E. COLI CHUA MUTANT CAPABLE OF INTERACTING WITH
V. CHOLERAE TONB1
To investigate the relevance of the TonB box –1 position for TonB
specificity, a comparison of E. coli and V. cholerae receptor sequences was
carried out.  The comparison shows that V. cholerae HutA and HutR, both of
which use V. cholerae TonB1, contain an aromatic residue immediately prior to
the TonB box (Fig. 17, page 134).  In contrast, the V. cholerae TonB2-dependent
receptors IrgA, VctA, and HasR all carry an acidic residue at this position.
Further, none of the E. coli receptors contain an aromatic residue at the TonB box
–1 position, and these receptors are not recognized by V. cholerae TonB1.  To test
the hypothesis that an aromatic amino acid at the position immediately preceding
the TonB box permits interaction with V. cholerae TonB1, an aromatic residue
was introduced into the E. coli  heme receptor, ChuA, at this position.  ChuA
carrying Phe in place of Thr at the TonB box –1 position was tested for
dependence on E. coli TonB or V. cholerae TonB1.  Table 17 shows that, whereas
V. cholerae TonB1 failed to recognize wild type ChuA, TonB1 interacted
productively with the ChuAT1F variant, facilitating heme utilization via this mutant
receptor.  These data suggest that receptor recognition by V. cholerae TonB1 is
determined by the residue immediately preceding the TonB box, further
implicating this region of the receptor in the interaction with TonB.  As was
observed for the FepA Asp11Tyr mutation, the Thr1Phe mutation in ChuA did
not abolish interactions with E. coli TonB; heme was used as efficiently via
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Table 17.  TonB-dependence of ChuA and ChuAT1F in E. coli.
Zone of growth (mm) after 48 hoursa
ARM100 (TonB-, EntF-)
transformed with:
Relevant Phenotypeb FeSO4 Enterobactin Hemin
pWKS30∆X/pChuA TonB-, ChuA+ 22 NG NG
pAMT111/pChuA eTonBX+, ChuA+ 20 28 16
pAMT112/pChuA vTonB1X+, ChuA+ 21 NG NG
pAMT111/pChuAT1F eTonBX
+, ChuAT1F
+ 22 28 15
pAMT112/pChuAT1F vTonB1X
+, ChuAT1F
+ 21 NG 14
a.  The indicated strains were seeded at 106 cells per ml into molten L agar containing 100 µg EDDA per ml.  Iron
sources were spotted onto the solidified agar as follows:  20 µl 10 mM FeSO4; 5 µl 40 µM Ferrichrome; 5 µl
DH5α overnight culture (enterobactin); 5 µl 50 µM hemin.  NG = No growth.  Plates were incubated for 24 hrs
at 37°C, then for 24 hrs at room temperature, and the diameter of each zone of growth was measured.  The
assays were repeated at least 3 times.  Although the relative differences between strains were consistent
between experiments, the absolute values for each strain varied due to subtle changes in the media and assay
conditions, and thus only one representative experiment is shown.
b.  e denotes  E. coli; v denotes V. cholerae.
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ChuAT1F as via wild type ChuA in the presence of E. coli TonB.  Thus, E. coli
TonB appears not to have stringent requirements for the TonB box –1 position.
8.  DIFFERENCES IN THE ACTIVITY AND/OR SPECIFICITY OF TONB PROTEINS
EXPRESSED IN E. COLI VERSUS V. CHOLERAE
A functional V. cholerae heme transport system can be reconstituted in E.
coli by supplying both HutA and the V. cholerae TonB1 heme transport locus.  In
contrast, E. coli cells expressing HutA and V. cholerae TonB2 did not use heme
(data not shown), suggesting that HutA may be specific for V. cholerae TonB1.
However, data presented in this dissertation (Table 6, page 102) clearly
demonstrate that V. cholerae TonB2 promotes heme uptake via HutA in
V. cholerae , suggesting that differences in the E. coli and V. cholerae
environments contribute to the observed specificities of E. coli and V. cholerae
TonB proteins.
Poor heme utilization in E. coli strains expressing the V. cholerae heme
receptors HutA or HutR (data not shown) and E. coli TonB may signify that these
receptors lack several or all of the sites required for functional interactions with E.
coli TonB.  However, it is also possible that the environment of the E. coli
periplasm influences the ability of E. coli TonB to make productive contacts with
the V. cholerae receptors.  To test whether E. coli TonB interacts with V. cholerae
receptors in V. cholerae, the E. coli tonB, exbB, and exbD genes were expressed
in the V. cholerae TonB defective strain DHH11.  E. coli TonB facilitated near
wild type levels of utilization of all the iron sources tested, showing that E. coli
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TonB recognizes at least one receptor for each of the substrates tested, including
one or both of the major V. cholerae heme receptors HutA and HutR (Table 18).
This suggests that E. coli TonB interacts with a similar range of receptors in V.
cholerae as V. cholerae TonB2.  E. coli TonB also interacted productively with
the TonB2-dependent heme receptor HasR.  This was demonstrated by expressing
a chimeric TonB protein with E. coli TonB specificity in the hutA, hutR mutant
ARM219.  The v1/e TonB chimera had the same range of activities in the V.
cholerae tonB mutant DHH11 as the full-length eTonB protein, and promoted
heme uptake via HasR in ARM219 (Table 18).  The v1/e chimera was chosen for
these experiments in order to circumvent the requirement for the E. coli exbB,
exbD plasmid, since this chimera carries the V. cholerae TonB1 N-terminus and
uses V. cholerae ExbB1 and ExbD1.
Because of the differences in results obtained in E. coli versus V. cholerae,
it was important to establish whether the specificity exhibited by V. cholerae
TonB1 in E. coli is relevant to the receptor bias displayed by TonB1 in
V. cholerae.  To answer this question, the V. cholerae TonB1XP237*T variant, which
interacts with E. coli receptors, was tested for ability to facilitate enterobactin
transport in V. cholerae, a process that normally requires the TonB2 complex
(149).  A halo assay demonstrated that, in addition to carrying out all the normal
TonB1 functions, the TonB1XP237*T protein conferred enterobactin utilization in
the tonB mutant strain DHH11, presumably by interacting with one or both of the
V. cholerae enterobactin receptors IrgA and VctA (Table 19).  These data
demonstrate that the C-terminal Pro237Thr substitution in TonB1 effectively
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Table 18.  Function of E. coli TonB in V. cholerae.  
Zone of growth (mm) after 24 hoursa
Strain/plasmid TonB present FeSO4 Ferrichrome Hemin Vibriobactin Enterobactin
DHH11 (Vib-, TonB-)/
   pWKS30 No TonB 21 NG NG NG NG
   pAMT112 vTonB1X 20 12 15 20 NG
   pOUT11 vTonB2 21 12 11 21 25
   peTonBX/pKP298c eTonBX 20 12 15 18 20
   pAMT114 v11-121/e120-239TonBX 20 12 16 17 19
ARM219 (DHH11 HutA-,
HutR-, HasR+)/
   pAMT112 vTonB1X 22 12 NG 21 NG
   pOUT11 vTonB2 20 11 7 (faint) 21 25
   pAMT114 v11-121/e120-239TonBX 21 12 8 (faint) 19 20
a.  The indicated strains were seeded at 106  cells per ml into molten L agar containing 100 µg EDDA per ml.  Iron sources
were spotted onto the solidified agar as follows:  20 µl 10 mM FeSO4; 5 µl CA401 overnight culture (vibriobactin); 5
µl  DH5α overnight culture (enterobactin); 5 µl 50 µM hemin.  NG=No growth.  Plates were incubated for 24 hrs at
37°C, and the diameter of each zone of growth was measured.  The assays were repeated at least 3 times.  Although the
relative differences between strains were consistent between experiments, the absolute values for each strain varied due
to subtle changes in the media and assay conditions, and thus only one representative experiment is shown.
b.  e denotes  E. coli; v denotes V. cholerae.
c.  pKP298 encodes E. coli ExbB and ExbD.
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Table 19.  Function of V. cholerae TonB1X∆ and TonB1XP237*T in V. cholerae.  
Zone of growth (mm) after 48 hoursa
Strain/plasmid TonB present FeSO4 Ferrichrome Hemin Vibriobactin Enterobactin
DHH11 (Vib-, TonB-)/
   pWKS30 No TonB 21 NG NG NG NG
   pAMT112 TonB1X 20 12 15 20 NG
   pOUT11 TonB2 21 12 11 21 25
   pAMT112∆ TonB1X∆ 21 13 15 20 NG
   pAMT112.m1 TonB1XP237*T 20 11 15 21 18
ARM219 (DHH11
HutA-, HutR-, HasR+)/
   pAMT112 TonB1X 22 12 NG 21 NG
   pOUT11 TonB2 20 11 7 (faint) 21 25
   pAMT112∆ TonB1X∆ 22 12 NG 22 NG
   pAMT112.m1 TonB1XP237*T 22 12 NG 20 18
a.  The indicated strains were seeded at 106  cells per ml into molten L agar containing 100 µg EDDA per ml.  Iron sources
were spotted onto the solidified agar as follows:  20 µl 10 mM FeSO4; 5 µl CA401 overnight culture (vibriobactin); 5
µl  DH5α overnight culture (enterobactin); 5 µl 50 µM hemin.  NG=No growth.  Plates were incubated for 24 hrs at
37°C, and the diameter of each zone of growth was measured.  The assays were repeated at least 3 times.  Although the
relative differences between strains were consistent between experiments, the absolute values for each strain varied due
to subtle changes in the media and assay conditions, and thus only one representative experiment is shown.
b.  All strains are derived from CA40130, and thus are Vib-.
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widens the range of receptors that TonB1 can interact with in V. cholerae.  The
data further imply that the molecular basis for receptor discrimination by TonB1
is similar in V. cholerae and in E. coli.  Interestingly, TonB1X carrying the
Pro237*Thr mutation did not mediate heme utilization in the hutA, hutR mutant
ARM219, suggesting that the heme receptor HasR specifically requires features
of TonB2 that are not supplied by TonB1 or the TonB1P237T variant (Table 19).
V. cholerae TonB1 is longer than TonB1 by 38 amino acids, raising the
possibility that the failure of TonB1 to recognize certain receptors in V. cholerae
is related to its length, rather than to a lack of specific residues required for the
productive interaction with these receptors.  To test this hypothesis, a TonB1
mutant containing a 35 amino acid deletion spanning the proline-rich region (149)
was tested for ability to mediate transport of various iron sources in V. cholerae.
Strains expressing TonB1∆ used vibriobactin, ferrichrome, and hemin as sources
of iron, indicating that the deletion did not adversely affect TonB1 function under
the conditions tested.  However, the TonB1∆ mutant, although comparable in
length to TonB2, did not facilitate enterobactin utilization, or utilization of hemin
via HasR (Table 19).  Thus, the receptor specificity exhibited by TonB1 in V.
cholerae is not likely to be due solely to it being longer than TonB2.
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IV.  DISCUSSION
V. cholerae encodes three functional heme receptors, HutA, HutR, and
HasR.  The V. cholerae heme receptors share many of the conserved features of
TonB-dependent outer membrane transporters, and all three receptors have
accordingly been assigned to COG1629 (Clusters of Orthologous Groups) in the
National Center for Biotechnology Information phylogenetic classification of
proteins encoded in complete genomes (165).  COG1629 contains outer
membrane receptor proteins, most of which are dedicated to TonB-dependent iron
or vitamin B12 transport.  There are currently seven V. cholerae COG1629
members.  In addition to the heme receptors, they include ViuA (receptor for
vibriobactin), FhuA (receptor for ferrichrome), BtuB (putative receptor for
vitamin B12), and IrgA (receptor for enterobactin).  At least two other outer
membrane proteins involved in iron transport, VctA (receptor for enterobactin;
Mey et al., manuscript in preparation) and VhrA (putative siderophore receptor,
substrate unknown; A. R. Mey, unpublished results) have been found in V.
cholerae (Table 20).  These receptors were not included in the COG database
because the V. cholerae El Tor 016961 genome database sequence contains
inactivating mutations in the genes encoding these receptors.  It is striking that
three of the nine V. cholerae TonB dependent receptors are involved in heme
transport, perhaps reflecting the importance of heme acquisition for this pathogen.
The presence of multiple receptors for heme substrates is not without precedent
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among bacterial pathogens.  H. influenzae, for example, expresses four different
TonB-dependent outer membrane proteins involved in heme acquisition (37, 115).
Most of the iron present in the mammalian host is in the form of heme,
and thus it is not surprising that the human pathogen V. cholerae can use heme as
an iron source.  The ability to take advantage of host heme reservoirs has been
correlated with virulence in several human pathogens, including N. meningiditis
(159), and the heme auxotrophs H. influenzae (78), and H. ducreyi (2, 156).
However, the relationship between heme acquisition and virulence is more
complex in V. cholerae, a pathogen that is non-invasive and does not have a
requirement for exogenous heme.  V. cholerae expresses multiple high affinity
iron uptake systems, and V. cholerae strains defective in all TonB-dependent
transport systems were severely impaired in the ability to colonize infant mice,
emphasizing the importance of TonB-dependent iron acquisition for the
pathogenesis of V. cholerae (70, 149).  In contrast, a V. cholerae strain defective
in hutA alone was not significantly compromised in growth in vivo in a rabbit ileal
loop model, or in vitro using hemin as the iron source (164).  We show here that
the ability of a hutA mutant to use hemin as an iron source is due to the presence
of additional receptors for heme, and not, as previously proposed, to siderophore-
mediated iron uptake (164).  To completely abolish hemin utilization in V.
cholerae, it was necessary to create a triple hutA, hutR, hasR mutant.
Interestingly, this triple heme receptor mutant was not at a competitive
disadvantage in the infant mouse model compared to its Vib- parent, indicating
that additional sources of iron are available to V. cholerae colonizing the
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mammalian host.  It is feasible that heme is more important in later stages of the
infection when release of heme proteins may occur due to cell sloughing and
tissue damage.  The ability to take up the released heme and accumulate iron prior
to exiting the mammalian host may aid in the survival of the pathogen in the
external environment, and thus increase its chances for gaining access to a new
host.
Hemoglobins derived from marine organisms may be another source of
heme-iron for V. cholerae.  Studies have shown that a variety of filter-feeding
marine organisms accumulate V. cholerae to high levels when exposed to
seawater containing V. cholerae (49, 116).  The persistence of V. cholerae within
these hosts may be determined by the availability of nutrients such as iron.  We
demonstrate here that V. cholerae can use marine invertebrate hemoglobins as a
source of iron, and that this iron acquisition requires the presence of a functional
heme receptor.  Because these hemoglobins readily release their heme under
oxidizing conditions, it is difficult to assess in the laboratory whether utilization
of these types of hemoglobin by V. cholerae requires any specific mechanism for
release of the heme moiety.  The marine invertebrate hemoglobins are typically
much less stable than the vertebrate hemoglobins (A. F. Riggs, personal
communication), and thus free heme is potentially available to V. cholerae
growing in association with its marine hosts.  Shellfish infected with V. cholerae
are often implicated in the transmission of V. cholerae to the human host (137),
and it is therefore important to gain a better understanding of the survival and
growth of this pathogen within marine ecosystems.
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The V. cholerae heme receptor HutR most resembles HutA and other
known Vibrio heme receptors.  HutR carries the FRAP motif that is well
conserved among heme receptors.  It should be noted, however, that many non-
heme receptors have a functionally similar sequence, such as YKAP in the E. coli
enterobactin receptor FepA, and this motif may be important for receptor function
independent of ligand specificity.  HutR has only 50% homology to the NPNL
consensus sequence located C-terminal to the FRAP box, and this motif is less
well conserved among the Vibrio heme receptors.  Secondary structure
predictions for both HutA and HutR, based on the solved E. coli FepA structure,
localize the conserved histidine residue found in the FRAP/NPNL region to a
putative extracellular loop, consistent with a potential role in heme binding.  A
similar prediction was made for the location of the corresponding histidine
residue in Y. enterocolitica HemR, and site-directed mutagenesis confirmed a role
for this residue in heme utilization (11).
HasR is most similar to the HasR hemophore receptors from
P. aeruginosa and S. marcescens.  V. cholerae HasR has only 50% identity to the
FRAP/NPNL consensus motifs, and, unlike Pseudomonas and Serratia HasR,
V. cholerae HasR does not contain the conserved histidine residue in the
FRAP/NPNL region (data not shown).  Thus, HasR may employ a different
mechanism for heme binding and/or transport.
HutA and HutR are both efficient heme transporters; however, HutA was
required for optimal hemin utilization in our assays.  Loss of HutR alone did not
affect the ability of V. cholerae to grow using hemin as the sole iron source,
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whereas loss of HutA resulted in a measurable decrease in hemin utilization.
HutA may have a higher affinity for its substrate, or may be a more effective
transporter than HutR.  It is also possible that HutA is expressed more efficiently
in low iron conditions.  HutA, but not HutR, was visible in outer membrane
preparations from wild type cells grown in low iron media, consistent with higher
expression of hutA than hutR under these conditions.  Although similar levels of
expression were detected from the hutA and the hutR promoters in low iron, hutR
expression may be subject to regulation not detected in our assays.
HutA was required for hemoglobin utilization under all conditions tested.
This suggests that HutA may bind hemoglobin directly; however, a previous
experiment demonstrated that V. cholerae does not bind hemoglobin to its surface
efficiently (S. M. Payne, unpublished results).  Furthermore, while both TonB
systems promoted heme uptake via HutA, only TonB1 mediated hemoglobin
utilization.  The ability of TonB2 to facilitate transport via HutA of free heme, but
not heme derived from hemoglobin, is difficult to explain if HutA binds both
heme and hemoglobin.  Whether or not hemoglobin associates with HutA, it is
likely that the heme portion is released prior to transport into the cell.  Growth
curve experiments (Fig. 10, page 96) indicated that the amount of heme released
may be limiting, and it is conceivable that only the HutA-TonB1 pair transports
heme efficiently enough to sustain growth under limiting conditions.
Expression from the hutR operon promoter was strongly induced in low
iron conditions.  Because genes involved in iron acquisition are typically iron-
regulated, the regulation of hutR expression by iron was expected.  However, the
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hutR operon also contains three genes of unknown function, as well as the ptrB
gene, and the significance of this genetic organization is not clear.  Many bacterial
heme receptors are encoded within multi-gene loci dedicated to heme transport
(58), yet we found no evidence that any of the genes linked to hutR participate in
utilization of heme or hemoglobin.  It is possible that there is redundancy, as is
often the case in V. cholerae, and, thus, expression of other genes may
compensate for the loss of these genes.  However, the function of these genes may
be unrelated to iron acquisition, even though they are iron-regulated.  There are
many examples of bacterial virulence genes that are upregulated in response to the
low iron levels encountered in the mammalian host (129).  Interestingly, V.
cholerae PtrB has significant homology to the Trypanosoma cruzi oligopeptidase
B, which is an important virulence factor in this human pathogen (27).
The finding that V. cholerae encodes a functional heme receptor with
homology to the HasR-type hemophore receptors suggested that V. cholerae may
also produce a HasA-like hemophore.  However, no hasA homolog was found in
the genome of V. cholerae El Tor N16961.  The hasA gene may have been lost
from this strain, or the hasR gene, which is typically linked to the hasA gene, may
have been acquired independently of hasA.  HasA and HasR are both required for
efficient hemoglobin utilization in Pseudomonas and Serratia species.  In
contrast, V. cholerae HasR did not appear to be necessary for hemoglobin
utilization.  Thus, if V. cholerae encodes a hemophore, it may be structurally and
functionally different from the known HasA hemophores.
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Heme uptake in V. cholerae is a TonB-dependent process, and data
presented in this study support earlier observations that both TonB systems
participate in heme acquisition.  The two TonB systems exhibit differences in
heme receptor specificities and in the efficiency of heme substrate utilization via
these receptors.  These differences may allow V. cholerae to maximize heme
acquisition under a variety of conditions.  TonB1 functions with both of the major
heme receptors HutA and HutR, but does not recognize the third receptor HasR.
Nonetheless, TonB1 is required for optimal heme acquisition by the cell under
standard laboratory conditions, emphasizing that HasR plays only a minor role in
heme acquisition under the conditions tested.  TonB1 is also required for heme
uptake under conditions of high osmolarity (149), indicating that TonB1 may be
particularly important for heme acquisition in the marine environment.  Further,
the TonB1 system is required for the ability of V. cholerae to use mammalian
hemoglobin as an iron source (149), suggesting a role for the TonB1 system in
heme acquisition within the human host as well.  The unique contribution of the
TonB2 system to heme utilization in V. cholerae is to facilitate heme uptake
through HasR.  The relevance of this contribution is not clear, since no particular
heme substrates or assay conditions were identified that specifically required
TonB2 or HasR.
The TonB box regions of HutA (68) and HutR are similar to each other
and to those found in other Vibrio heme receptors, including V. vulnificus HupA
(106), V. anguillarum HupA (GenBank accession no. CAC28362), and
V. mimicus MhuA (GenBank accession no. BAB33171).  In contrast, the
156
V. cholerae HasR sequence does not correspond well to the other Vibrio heme
receptors in this region (Fig. 17, page 134).  Because TonB1 promotes heme
transport through HutA and HutR, but not through HasR, it is possible that TonB1
specifically requires a HutA- or HutR-like TonB box.  The conservation of this
type of TonB box across many of the Vibrio heme receptors may reflect their
dependence on a TonB1-like molecule for optimal transport function.  This
appears to be the case in V. cholerae, which relies on the TonB1 system for
optimal heme transport, as well as for the utilization of hemoglobin as an iron
source.  An even more striking example is V. alginolyticus, which encodes two
TonB systems similar to V. cholerae TonB1 and TonB2, and is completely
dependent upon expression of its tonB1 system-like genes for heme utilization
(123).
The ability to express V. cholerae genes in E. coli has been very useful for
identifying V. cholerae genes involved in iron transport.  Nevertheless, it is
important to recognize that the activities of V. cholerae gene products within the
E. coli environment may not accurately reflect their activities in V. cholerae.  The
failure of TonB2 to satisfy the TonB requirements of either HutA or HutR in
E. coli was surprising, given that TonB2 is functional in E. coli (124) and was
able to facilitate transport through both receptors in V. cholerae.  Seliger et al.
(149) showed that heme uptake in V. cholerae is sensitive to increases in
osmolarity and that this sensitivity correlates with the ability of the TonB
molecules to span the periplasmic space (149).  It is conceivable that subtle
differences between the V. cholerae and E. coli periplasmic environments account
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for the failure of the TonB2 complex to mediate heme transport through HutA or
HutR in E. coli.  Some caution should therefore be exercised when interpreting
studies of V. cholerae iron transport systems expressed in E. coli.
TonB1 exhibits a narrower specificity than TonB2.  While TonB2
promoted transport through all of the V. cholerae and E. coli receptors tested in
this study, TonB1 recognized none of the E. coli receptors and only a subset of
V. cholerae receptors.  The specificity of TonB1 cannot be attributed solely to its
longer length compared with TonB2, since a shortened TonB1 had the same
specificities as the full-length TonB1.  Furthermore, TonB1 exhibited the same
specificities in both the V. cholerae and E. coli environments.  Thus, the receptor
discrimination displayed by TonB1 likely represents a true requirement for
particular interaction sites.  Such a specificity is consistent with a more
specialized role for TonB1 in the life cycle of V. cholerae.  While TonB2 is
encoded on the large chromosome along with the V. cholerae housekeeping
genes, the TonB1 system genes are located on the smaller replicon, and were
probably acquired by horizontal transfer.  The tonB1 locus may have been
maintained during the evolution of this pathogen in order to cope with specific
environments such as the marine environment, or the human intestinal tract.
Despite the differences in receptor specificities between V. cholerae
TonB1 and E. coli TonB, their comparable lengths and overall sequence
similarities made it feasible to construct functional chimeras between these two
TonB proteins.  The functional domain organization in the two TonB proteins
appears to very similar.  The N-terminal domain of V. cholerae TonB1 is specific
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for V. cholerae ExbB1 and ExbD1 proteins, consistent with direct interactions
between the TonB1 N-terminus and the ExbB1, ExbD1 complex in the inner
membrane.  This is the case also for the E. coli TonB N-terminal domain, which
requires a set of E. coli ExbB, ExbD accessory proteins in order to function in
V. cholerae (data not shown).  Like E. coli TonB, V. cholerae TonB1 contains a
central proline-rich region.  This region appears to be necessary for the TonB
molecule to traverse the increased periplasmic space under conditions of high
osmolarity, but is otherwise dispensable for TonB function (91, 149).  Finally,
secondary structure predictions for the V. cholerae TonB1 C-terminus indicate
that V. cholerae TonB1 may contain several of the secondary structural elements
found in E. coli TonB, including a putative α-helical domain that aligns with the
amphipathic helix within the E. coli TonB C-terminal dimerization domain (data
not shown).  This suggests that V. cholerae TonB1 may adopt a domain structure
at the C-terminus similar to that of E. coli TonB.
The C-terminus of TonB determines the specificity of the interaction
between TonB and TonB-dependent receptors.  In the case of E. coli TonB, the C-
terminal 66 residues were sufficient for recognizing E. coli receptors.  These 66
residues may represent the minimal region required to reconstitute a functional
E. coli TonB C-terminal dimerization domain.  Although at least 75 residues were
found to participate in E. coli TonB dimerization (31), the first nine of these
residues may not be required to form the dimer.  Alternatively, the residues
contributed by V. cholerae TonB1 may be similar enough to the corresponding
residues in E. coli TonB to permit the formation of a functional dimer.  V.
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cholerae TonB1 requires between 66 and 81 residues to form a functional C-
terminal domain.  Thus, the putative V. cholerae TonB1 C-terminal dimer may
involve a greater number of residues, or have more stringent amino acid
requirements than the E. coli TonB dimer.
None of the chimeras involving fusions within the core of the C-terminal
dimerization domain of E. coli TonB were functional.  This is not surprising,
given the tightly intertwined nature of the C-terminal dimer.  Each TonB
molecule contributes three β-strands to the large antiparallel β-sheet covering
most of the dimer surface, and these strands are connected by an extensive
network of hydrogen bonds (31).  It is therefore unlikely that even a small number
of amino acid substitutions would be tolerated within this region.
Residues surrounding Glu160 in E. coli TonB have been implicated in the
direct interaction with the TonB box of the BtuB receptor (25).  Nevertheless, this
stretch of amino acids is not involved in determining specificity for E. coli
receptors, since a chimera containing the E. coli TonB C-terminus, but not the
Glu160 region, was able to interact productively with all the E. coli receptors
tested.  Further, the Glu160 residue, as well as many of the neighboring amino
acids, are conserved in V. cholerae TonB1, arguing against a role for this region
in specificity.  However, this does not exclude a role for these residues in the
TonB-receptor interaction(s).  Although the Glu160 region is not required for
dimerization, its proximity to the dimerization domain suggests that it could form
part of a C-terminal receptor-binding site.  Alternatively, the Glu160 region may
interact with TonB independently of the C-terminal dimerization domain.
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In interpreting the results of studies with chimeric TonB proteins, it is
important to note that aberrant expression of the hybrid proteins may have
contributed to the observed activities and specificities.  It is possible that
overexpression of a poorly functioning TonB hybrid could permit wild type levels
of transport, and could mask any subtle changes in receptor specificity.
Conversely, the observed lack of activity of a TonB chimera could be due to poor
expression of the hybrid protein rather than to non-productive receptor
interactions.  Thus, while the results obtained from these hybrid TonB studies are
in good agreement with the current understanding that the carboxy terminus is
important for receptor recognition, they do not unambiguously subdivide the C-
terminal domain further.
The specificity of V. cholerae TonB1 towards receptors in both
V. cholerae and E. coli appears to be determined by the very C-terminal end of
the TonB molecule.  A Pro237Thr substitution in V. cholerae TonB1 resulted in
the ability of TonB1 to recognize at least one TonB2-dependent V. cholerae
receptor, as well as multiple E. coli receptors.  Based on a CLUSTAL-W
alignment, the V. cholerae TonB1 Pro237 residue corresponds to Asn227 in E. coli
TonB.  Interestingly, Asn227 is positioned on the β-sheet face of the cylindrical E.
coli TonB dimer in such a way that the two Asn227 residues, one from each TonB
molecule, are in close proximity to each other and almost directly opposite the
cleft formed by the two α-helices (Fig. 19).  The α-helix cleft was proposed as a
binding site for outer membrane receptors, since this region exhibits significant
flexibility and forms a motif that could feasibly accommodate a receptor
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Figure 19.  Three-dimensional model of the E. coli TonB dimer showing the
position of Asn227.
This figure was generated using Cn3D to view the 3-dimensional structure of
E. coli TonB from the NCBI Entrez Structure database
(http://www.ncbi.nlm.nih.gov/Structure/mmdb/mmdbsrv.cgi?form=6&db=t&Dop
t=s&uid=16883)
A .  View from the β-sheet face of the intertwined TonB dimer.  The TonB
monomers are shown in red and gray, respectively.  The two Asn227 residues are
highlighted in yellow.  The figure shows the proximity of the two Asn227 residues
to each other in the antiparallel β-sheet.
B.  View from the α-helix face of the TonB dimer, showing the two highlighted
Asn227 residues positioned at the bottom of the putative binding cleft formed by
the α-helices.
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domain (31).  Insertion of a receptor domain into the binding cleft might bring
this domain into close contact with the two Asn227 residues at the bottom of the
putative binding pocket.
While the positioning of the Pro237Thr gain-of-function mutation in
V. cholerae TonB1 seems logical, the particular relevance of substituting Thr for
Pro is less clear.  The Thr residue may be able to participate in a hydrogen-
bonding pattern similar to that of the equivalent Asn residue in E. coli TonB.
Alternatively, this substitution may affect other residues involved in receptor
binding.
It was surprising that no gain-of-function mutations were isolated in the
putative C-terminal α-helix domain in V. cholerae TonB1.  Not only does the α-
helix domain form a putative binding cleft, but these residues are well conserved
between E. coli TonB and V. cholerae TonB2, which have similar specificities,
and quite different in V. cholerae TonB1.  It is possible that this region does
contain specificity determinants, but that the β-sheet mutation has a dominant
effect on the specificity of the receptor interaction.
The Pro237Thr mutation in V. cholerae TonB1 resulted from a single base
pair change in tonB1.  This mutation did not appear to interfere with any of the
normal TonB1 functions.  Rather, the effect of the mutation was to widen the
range of receptors that TonB1 can interact productively with in V. cholerae.  It
seems almost surprising, therefore, that this mutation has not been selected for
during the evolution of V. cholerae as a pathogen.  One possibility is that the
mutation permits TonB1 to interact with the enterobactin receptor IrgA, which
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normally only recognizes TonB2.  Since IrgA is the most abundantly expressed
TonB-dependent receptor in V. cholerae, interactions with this receptor might
sequester the available TonB molecules to such an extent that transport of other
substrates, including heme and vibriobactin, is affected.  It is also conceivable that
the TonB1P237T mutation has an adverse effect on TonB1 function that is not
detectable under the assay conditions used.
The TonB box is an important functional domain in TonB-dependent
receptors.  Several mutations have been identified within this domain of E. coli
FepA and BtuB that eliminate substrate transport without affecting substrate
binding, indicating that this domain may be required for TonB-dependent
transport functions (4, 7, 24, 87).  A comparison of E. coli and V. cholerae
receptor TonB boxes suggested that this region may contain residues involved in
determining the specificity of the TonB-receptor interactions.  However, domain-
switching experiments showed that the TonB box heptapeptide does not represent
a specificity module.  E. coli ChuA carrying the V. cholerae HutA TonB box
exhibited the same specificities as wild type ChuA.  Substituting the TonB box of
HutA with that of ChuA appeared to strengthen the weak interactions with E. coli
TonB, but interactions with V. cholerae TonB1 were unaffected, suggesting that
the specificity of the receptor had not changed.  Interestingly, HutA did not
tolerate insertion of the FepA TonB box, even though there are more conserved
residues between the HutA and FepA TonB boxes than between the HutA and
ChuA TonB boxes.  The mutation responsible for the transport defect in HutA
carrying the FepA TonB box may be the Val to Ile substitution at the third
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position within the HutA TonB box.  All the other FepA residues introduced into
HutA were identical to the equivalent ChuA TonB box substitutions, and these
did not inhibit transport through HutA.  The third residue in the TonB box
heptapeptide may be particularly sensitive to mutations, since a variety of
substitutions at this position are associated with transport defects also in FepA and
BtuB (4, 7, 24, 87).
While the TonB box itself does not determine the specificity of the TonB-
receptor interactions, the amino acid residue immediately preceding the TonB box
domain had a profound impact on the ability of E. coli receptors to recognize
V. cholerae TonB1.  Insertion at this position of a Tyr residue in E. coli FepA, or
a Phe residue in E. coli ChuA, allowed these receptors to interact productively
with V. cholerae TonB1, suggesting that TonB1 may specifically require an
aromatic residue directly prior to the TonB box.  This hypothesis is supported by
the finding that the V. cholerae heme receptors HutA and HutR, both of which
recognize TonB1, carry aromatic residues at the TonB box –1 position.
Alternatively, the TonB1 specificity may be determined by a restriction against,
rather than a requirement for, a certain type of residue in this position.  All of the
known V. cholerae TonB2-dependent receptors, as well as many of the E. coli
receptors, contain an acidic residue immediately before the TonB box, and
perhaps this particular type of amino acid inhibits productive interactions with
TonB1.  Whatever the case, the data strongly imply that the extreme N-terminus
of the receptor is involved in determining the specificity of the TonB interactions.
It is likely, therefore, that this receptor region contacts TonB directly.  These
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findings may necessitate a redefinition of the TonB box functional domain to
include the TonB box –1 position.
Although many aspects of TonB-dependent transport across the outer
membrane are not yet understood, a model can be proposed that integrates both
structural and genetic data relating to this process.  Substrate binding at the
extracellular face of a TonB-dependent receptor results in a conformational
change in the binding loops that is propagated through the receptor to the very N-
terminus of the plug domain at the periplasmic face (108).  This conformational
shift causes the N-terminal TonB box domain to unfold and become available for
periplasmic interactions with TonB (109).  TonB specifically recognizes the
unfolded state of the TonB box, either because of the conformational changes in
the TonB box, or because the TonB box is no longer sequestered within the
receptor.  Specific recognition of the TonB box region by TonB probably involves
a binding site in the C-terminal dimerization domain.  This binding site may be
composed of the C-terminal α-helix binding cleft, as well as specific β-sheet
residues at the base of this putative binding pocket.  Interactions between the
TonB C-terminal dimer and the receptor TonB box domain may cause the plug
domain in the receptor to reorganize, and either squeeze against the barrel sides,
or exit the barrel pore entirely.  This plug domain reorganization is not, however,
sufficient for active transport of the substrate.  Further interactions with TonB are
required, as evidenced by the TonB-dependence of plugless receptor variants (13,
148).  By exposing an otherwise secluded TonB binding site in the β-barrel, the
rearrangement or removal of the plug domain could be a prerequisite for the
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interaction of TonB with the β-barrel domain. It is not currently known which
specific region(s) of the TonB C-terminus participate in the β-barrel interactions,
although it is conceivable that either the C-terminal dimerization domain, or the
Glu160 region are involved.  Either of these regions might also facilitate
repositioning of the TonB box in its sequestered position within the receptor pore
(109) after release of the substrate into the periplasm.  This, however, is highly
speculative.  It is not clear at which step in the transport process TonB discharges
its energy, but it is likely that energy is required for the reorganization of the plug
domain and/or the release of the substrate from its high-affinity binding site
within the receptor.  Energy may also be required for resetting the receptor after
one round of transport.  Structural analyses of TonB-receptor complexes trapped
at different stages of the transport process may be needed to answer these
questions.
In conclusion, data presented in this study demonstrate that V. cholerae
heme transport involves three separately encoded heme receptors.  These
receptors share some functional characteristics; however, there are unique features
associated with each receptor as well. V. cholerae can persist in a variety of
environments, both within and outside of the human host, and each receptor may
be uniquely adapted for heme acquisition under a particular set of conditions.
This study also provides evidence that the specificity exhibited by TonB1 for a
subset of V. cholerae receptors can be attributed to sequence features near the C-
terminus of TonB1 and near the N-terminus of the receptor.  This suggests that
functional interactions take place between the TonB C-terminal dimerization
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